Ceremonial Psychedelic Experiences and Changes in Mental Health Outcomes in Those with Adverse Childhood Experiences - Maryam K. Mehmood et al. 2026 journals.sagepub.com/doi/10.1177/28314425251392251
Robin Carhart-Harris
Robin Lester Carhart-Harris (born 31 August 1980) is a British psychopharmacologist who is Ralph Metzner Distinguished Professor in the Department of Neurology at the University of California, San Francisco. Previously, he founded and was Head of the Centre for Psychedelic Research at Imperial College London. More on Wikipedia
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
More Memory Lane stuff. 14 years ago now: Researchers discuss MDMA science youtu.be/YCr36wGEeyU via @YouTube
-
Robin Carhart-Harris reposted
Psychedelics.com
@psychedelicscom
Really cool! UCSF is looking for 3,000 people who plan on taking mushrooms or other psychedelics to share their experiences. sfist.com/2026/11/12/ucsf-launches-study-of-recreational-…
-
Robin Carhart-Harris
@RCarhartHarris
#1 🌍 ⚽️ 🏴 🦁 🦁 🦁
-
Robin Carhart-Harris
@RCarhartHarris
1440
-
Robin Carhart-Harris
@RCarhartHarris
Study Tracks 3,000 Real-World Psychedelic Journeys - neurosciencenews.com/psychopharmacology-psychedelic-journ… via @neurosciencenew
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
The level of response to this project has been overwhelming! Nearly 1K sign ups in just a few weeks… sfist.com/2026/11/12/ucsf-launches-study-of-recreational-… ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
Martijn Arns
@Brainclinics
The FDA’s first decisions on psilocybin, LSD and MDMA are expected in 2027. Where will you be when psychedelics enter clinical practice?
Our answer: Nijmegen (NL), March 17–19, at the TMS & Psychedelic Masterclass. One day on TMS certification, one on psychedelics, one on the latest in brain stimulation, with @RCarhartHarris, Rachel Yehuda, @NoahSPhilipMD, @JonathanDownar, Helena Aicher and Iris Dalhuisen.
Included with your registration: Robin’s 'How Psychedelics Work' book, published weeks before the course, and an option to have it signed by the author!
Registration open: brainclinics.com/masterclass/masterclass-2027 -
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
Plan to take a psychedelic? Don't forget to keep this in mind: www.youtube.com/watch?v=wvaz9NbOmiM
-
Robin Carhart-Harris
@RCarhartHarris
Recommended by @UCSF_AndrewPenn
-
Robin Carhart-Harris
@RCarhartHarris
Another memory lane moment. In hindsight, I believe we're misinterpreted the initial results at this point. I changed my mind some years later, and signs of that began in my 2014 entropic brain paper. Anyway, the memory: www.bbc.com/news/av/health-16694061
-
Robin Carhart-Harris
@RCarhartHarris
Going down memory lane. RIP Michael Mosley. Michael Mosley Takes a Psychedelic Drug - The Brain: A Secret History - BBC youtu.be/gWM09s5_Z-A via @YouTube
-
Robin Carhart-Harris reposted
Carl Cox
@Carl_Cox
I’m not quite sure I can put into words what today means to me.
Music has been my whole life. From those early days of falling in love with records and DJing, to travelling the world and sharing that love with so many people, I’ve never stopped being grateful that I get to do what I do.
To receive my OBE from Prince William at Windsor Castle today, recognising nearly 50 years of doing something I absolutely love, is beyond anything I could have imagined. ❤️🔥
I’ve been thinking a lot about my mum and dad today. I know just how proud they would have been, and I wish they could have been here to share this moment with me.
This honour means so much, not just to me personally, but because of where our music has come from and how far it has travelled. To see dance music recognised in this way is something I’m immensely proud of.
To my family, friends, everyone who has believed in me, supported me and danced with me over the years, thank you. You’ve all been part of this.
My heart is very full today. I’m proud, humbled and deeply honoured.
Thank you, Carl. -
Robin Carhart-Harris
@RCarhartHarris
Plan to take a psychedelic? Don't forget to keep this in mind: www.youtube.com/watch?v=wvaz9NbOmiM
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
CANOPY Launch Webinar - Carhart-Harris Lab youtu.be/r6uNkHH-8fg via @YouTube
-
Robin Carhart-Harris
@RCarhartHarris
Doing this in a mo @EudemoniaSummit Always a Great event here in West Palm Beach. Great space for psychedelic therapy. We’ll see more crossover into wellness space in coming years.
Robin Carhart-Harris
@RCarhartHarris
Coral DE
-
Robin Carhart-Harris
@RCarhartHarris
Speaking here in 40 mins. Coral A.B.C. @EudemoniaSummit
-
Robin Carhart-Harris
@RCarhartHarris
Overflowing cornucopia of health! @EudemoniaSummit
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Asked who I had in mind as the audience when I wrote my book: www.instagram.com/reel/DfUXiEYjjCZ/?rpxt=c3AxcmRqMDJnMm55 lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Terrance McKenna’s first DMT trip. “It didn’t seem like a state of mind, it seemed like another place.”
-
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
Nonprofit psychedelic research organisation Usona Institute has completed its submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) concerning its psilocybin candidate for major depressive disorder (MDD), Psychedelic Alpha understands.
It means it’s the second psychedelic NDA under review by the agency at present, after we reported that Resilient Pharmaceuticals (formerly Lykos Therapeutics) refiled its MDMA for PTSD application in the summer. It also means that FDA could hand down a decision on a psychedelic application in late 2026, if the most optimistic timelines hold, or very early in the new year, given the fact that Usona, like Compass Pathways, is in receipt of a Commissioner’s National Priority Voucher (CNPV) that aims to return a decision to a developer within two months.
In our latest, we review the context surrounding Usona’s program and application, and what it might mean for its chief competitor, Compass, a for-profit psilocybin drug developer that is planning to submit its own NDA, for treatment-resistant depression (TRD), imminently.
Read now on our website: psychedelicalpha.com/news/usona-files-psilocybin-for-depr… -
Robin Carhart-Harris
@RCarhartHarris
Feeling very honored to have received these blurbs, including the most recent from @carlorovelli www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
Robin Carhart-Harris
@RCarhartHarris
Still listed at the top here. Pre-order now? Christmas is coming… www.amazon.com/gp/new-releases/books/11172
-
Robin Carhart-Harris
@RCarhartHarris
Very nice work here. A case of the animal work making good translational sense: Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice www.biorxiv.org/content/10.64898/2026.04.21.720014v2 @kwanalexc
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Still listed at the top here. Pre-order now? Christmas is coming… www.amazon.com/gp/new-releases/books/11172
-
Robin Carhart-Harris
@RCarhartHarris
CANOPY Launch Webinar - Carhart-Harris Lab youtu.be/r6uNkHH-8fg via @YouTube
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Stellar work here by Patrick McConnell and Lorenzo Pasquini: www.nature.com/articles/s41398-026-04349-z
-
Robin Carhart-Harris
@RCarhartHarris
A reminder of this. This was the polite version: pubmed.ncbi.nlm.nih.gov/42455578/
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Pretty fatal flaws. The original work does not support the inferences that followed. It was a comparison of categorically distinct phenomena, with shocking bias in the open label TADs, they were borderline corrupt.
-
Robin Carhart-Harris reposted
Julie Holland, MD
@BellevueDoc
the quality of the relationship between a patient and their therapist was one of the strongest predictors of treatment outcome in a psilocybin study
not everyone needs a therapist in the room, obviously, but for people with TRD or PTSD... they likely do.
www.frontiersin.org/journals/pharmacology/articles/10.338… -
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Psychedelic therapy mental recalibration akin to an epigenetic reprogramming..?
-
Robin Carhart-Harris
@RCarhartHarris
Is mental illness in adulthood akin to epigenetic drift with ageing. Healthy canalization/development gets skewed in abnormal ways/ goes awry.
Robin Carhart-Harris
@RCarhartHarris
And both can be reset/reprogrammed…?
Robin Carhart-Harris
@RCarhartHarris
Psychedelic therapy mental recalibration akin to an epigenetic reprogramming..?
-
Robin Carhart-Harris
@RCarhartHarris
Here’s a curious twist. Ageing as a decanalizing body: www.nature.com/articles/s41586-026-10955-0
-
Robin Carhart-Harris reposted
Jesse Schmidt
@js_neuropsych
Proud to have helped launch CANOPY.
A global study exploring the diversity of real-world psychedelic experiences, bridging a critical gap in our understanding of expanded states of consciousness.
Here you can learn more + join the study:
Robin Carhart-Harris
@RCarhartHarris
ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris reposted
Psychedelic Lived Experiences
@psych_lived_exp
Learn more about the UCSF CANOPY project with @RCarhartHarris and participate if you can. More data leads to better decisions.
Robin Carhart-Harris
@RCarhartHarris
The more you share, the better WE can care. Please share this and see if you're eligible. www.youtube.com/watch?v=wvaz9NbOmiM Direct link to sign up survey here: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6 and see more in my second post...
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
This media couldn't be displayed. See it on the original post.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
The more you share, the better WE can care. Please share this and see if you're eligible. www.youtube.com/watch?v=wvaz9NbOmiM Direct link to sign up survey here: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6 and see more in my second post...
Robin Carhart-Harris
@RCarhartHarris
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Watch this for a deeper dive on the UCSF CANOPY project.
Robin Carhart-Harris
@RCarhartHarris
And here's that direct link again: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
Gratitude and a very well done to Aline and Grace for continuing to address an important knowledge gap here: link.springer.com/article/10.1007/s00213-026-07177-7
-
Robin Carhart-Harris reposted
England
@England
The best player in the world.
Our 2026 #ballondor winner: HARRY KANE! 🏴🏆 -
Robin Carhart-Harris reposted
BryanRoth
@zenbrainest
WOW!!
Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression jamanetwork.com/journals/jama/fullarticle/2855796 -
Robin Carhart-Harris
@RCarhartHarris
Wow! Harry Kane! Legend! So proud! @HKane @England 🏴 🦁 🦁 🦁
-
Robin Carhart-Harris reposted
Calley Means
@calleymeans
A historic reform that will save countless lives.
POLITICO
@politico
The Trump administration moves to treat millions of mentally ill veterans with psychedelics www.politico.com/news/2026/10/25/trump-psychedelics-veter…
-
Robin Carhart-Harris
@RCarhartHarris
Enjoying this. Andrew and I will compare notes on each other’s books with Evan mcGloughlin soon. @alieninsect @evan_mcgl @Graham__Hancock
-
Robin Carhart-Harris reposted
Karim Jerbi
@karimjerbineuro
Read our full open-access paper in Communications Biology, where we use MEG to reveal how LSD reshapes brain rhythms, spectral dynamics, and neural complexity.
www.nature.com/articles/s42003-026-10629-7
by @Venkateshness /w @RCarhartHarris @milthampton @giulia_lioi @AnnalisaPascar1 @yharel109 🙏 -
Robin Carhart-Harris
@RCarhartHarris
Many will struggle to see how this can be justified by evidence. Strictly, if the powers were to maintain S1 for psychedelics, they should move several other drugs/medicines into S1 for parity. But that would be absurd, so the only logical move is to reschedule psychedelics to match evidence.
Matthew W. Johnson
@Drug_Researcher
With all the momentum with psychedelics, this is the perhaps most important, ignored policy issue. Psychedelic medicine supporters will be astonished if/when MDMA & psilocybin are FDA approved but almost all of these substances remain schedule I. Spreading the word can help change that. @Ravarora1
www.illusionconsensus.com/p/psychedelics-could-remain-sch… -
Robin Carhart-Harris reposted
Andrew Gallimore
@alieninsect
Next on the reading list (after Cormac’s bio) by @RCarhartHarris…
-
Robin Carhart-Harris
@RCarhartHarris
Big News! I hope they don't repeat the MDMA for PTSD episode. I doubt they will.
Josh Hardman
@Josh__Hardman
So it's public, ICER will review COMP360 psilocybin for treatment-resistant depression
icer.org/news-insights/press-releases/institute-for-clini… -
Robin Carhart-Harris reposted
Martin Picard
@MitoPsychoBio
I've been writing the ENERGY book for more than a year—with all my early morning time, weekends, and a few productive writing retreats. This book weaves together the science of energy and our research on mitochondria with stories of lived experiences, including some of our own and many others. I also share practical evidence-based guidance on how to apply energetic principles into our lives: ways to live a scientifically-informed, energetically-inspired life.
The full draft is now with the publisher. The book should launch early 2028. Translated in nine languages so far. Can't wait to share this with everyone!
I am grateful for the amazing people who are working on bringing this book to life and sharing it with the world. More here: energy-book.com -
Robin Carhart-Harris
@RCarhartHarris
I’ve read 12 pages and laughed out loud 5 times already. That never happens! This is fun! Go Bobby! @BobbyAzarian
-
Robin Carhart-Harris
@RCarhartHarris
Thanks for the reposts!
@hubermanlab
@michaelpollan
Robin Carhart-Harris
@RCarhartHarris
Do you live in the San Francisco Bay Area? Are you planning a psychedelic experience? Willing to have an MRI before and a few weeks after? Maybe you're eligible for our study here: www.carhartharrislab.com/studies
-
Robin Carhart-Harris
@RCarhartHarris
An evolution carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
What I got from it.
-
Robin Carhart-Harris
@RCarhartHarris
Yup. My experience over the years. The self-perpetuating priesthood won out… But not forever…
-
Robin Carhart-Harris
@RCarhartHarris
I love these pages. Ego/shadow in science. Is it better or worse in psychedelic science?
Robin Carhart-Harris
@RCarhartHarris
Is interference from “Ego” better or worse in psychedelic science [vs science more generally]?
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
My book (How Psychedelics Work) has been receiving some fantastic endorsements, with Gabor Mate, Rick Doblin and some other A-list endorsements coming very soon. 🙏🙏 Pre-order here: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
Going down a regeneration rabbit hole
-
Robin Carhart-Harris reposted
Michael Pollan
@michaelpollan
Opportunity knocks!
Robin Carhart-Harris
@RCarhartHarris
Do you live in the San Francisco Bay Area? Are you planning a psychedelic experience? Willing to have an MRI before and a few weeks after? Maybe you're eligible for our study here: www.carhartharrislab.com/studies
-
Robin Carhart-Harris
@RCarhartHarris
Do you live in the San Francisco Bay Area? Are you planning a psychedelic experience? Willing to have an MRI before and a few weeks after? Maybe you're eligible for our study here: www.carhartharrislab.com/studies
Robin Carhart-Harris
@RCarhartHarris
This link takes you straight in: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
There’s some fantastic writing in this book.
Robin Carhart-Harris
@RCarhartHarris
A glaze of sentience, an ocean of mind: the noosphere.
Robin Carhart-Harris
@RCarhartHarris
Anima mundi, unus mundus, one soul
-
Robin Carhart-Harris reposted
Steve Jurvetson
@FutureJurvetson
Enjoying the chapter on psilocybin for anorexia, one of the deadliest psychiatric illnesses.
50% went into remission after two dosing sessions and continued to improve 3 months later. (p.189) -
Robin Carhart-Harris
@RCarhartHarris
This would be very silly.
Matthew W. Johnson
@Drug_Researcher
Sounding the alarm - if MDMA & psilocybin are approved by FDA, most MDMA & psilocybin could still be scheduled I, wildly inconsistent with the science. @Ravarora1 & I lay out the case for why we need to avoid a "bifurcated schedule" that only reschedules the commercial FDA approved product. Please repost & spread the word! www.illusionconsensus.com/p/psychedelics-could-remain-sch…
Robin Carhart-Harris
@RCarhartHarris
It would (further) make a mockery of the scheduling criteria.
-
Robin Carhart-Harris
@RCarhartHarris
Mock up of the dust jacket for my book is looking freaking cool! lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
Is it an Iris, is it a spore print? Or is it a 'Psychedelic Spiris'? lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
My granddad used to sing me this: open.spotify.com/track/66cBcj2BETtN7joIJHSsLA
-
Robin Carhart-Harris reposted
Julie Holland, MD
@BellevueDoc
LSD treatment affects working memory-related brain function in patients with major depressive disorder
www.nature.com/articles/s41398-026-04522-4_reference.pdf -
Robin Carhart-Harris reposted
Haley Maria Dourron
@HDourron
✨🧘🍄 New study 🍄🧘✨ Many people think that meditation & psychedelics might have similar effects. Our new study examines how beliefs & cognitive processes might be similar or different in consistent meditators versus psychedelic users
Share widely! -
Robin Carhart-Harris
@RCarhartHarris
I’m not enjoying this. Should I persist?
Robin Carhart-Harris
@RCarhartHarris
I loved his complete works but maybe this was meant (as he intended) to go unpublished?
-
Robin Carhart-Harris
@RCarhartHarris
Funny to look back on this after ~5 years. I guess I wasn't far off with the "3-5 year" estimate on when the phase 3 pivotal trials will be reading out... youtu.be/LERoXSd8_14
-
Robin Carhart-Harris reposted
Julie Holland, MD
@BellevueDoc
An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder
www.medrxiv.org/content/10.64898/2026.10.01.26364511v1.fu… -
Robin Carhart-Harris
@RCarhartHarris
The psychedelic therapist can do careful, quality prep, compassionate presence, subtle, artful and solid space holding, and wise and strong integration… But only the patient can do the healing…
-
Robin Carhart-Harris
@RCarhartHarris
And I’ve still got love the streets lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Still listed #1 hot new release. Pre-order here: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Another week, still #1 new release in my assigned category (Experimental Psychology)... Pre-order here: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Still #1. lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Around one month since pre-orders went live and still #1 new release, with around 1,100 pre-orders so far. Get yours? Write me if you wish to bulk order: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
Nice to see some quality science, pro-psychedelic medicine work coming out of China.
-
Robin Carhart-Harris
@RCarhartHarris
Curious 5-ht2a receptor rebound after mouse withdraws from 21 days of day-on-day off psilocybin “microdosing”
Robin Carhart-Harris
@RCarhartHarris
Presumably it’s because agonist has been withdrawn so receptor upregulates, a homeostatic mechanism ?
-
Robin Carhart-Harris
@RCarhartHarris
Just saying 😊✨🤷♂️ www.amazon.com/gp/new-releases/books/11172
-
Robin Carhart-Harris
@RCarhartHarris
Doing this here in San Diego. Integrative medicine and psychedelic medicine. It’s a wonderful match!
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Integrative medicine means an approach to healthcare that combines standard medical treatment with selected complementary approaches, while considering the whole person—physical health, mental well-being, lifestyle, and sometimes social factors.
-
Robin Carhart-Harris
@RCarhartHarris
Another little needle move. Grateful to be part of this impressive work on the human brain action of LSD: www.nature.com/articles/s42003-026-10629-7
-
Robin Carhart-Harris
@RCarhartHarris
No surprise, I’m very British Isle but got me learning about pedigree collapse & jungian archetypes.
Robin Carhart-Harris
@RCarhartHarris
So you could construct a naturalistic Jungian argument something like:
Deep shared ancestry + recurrent selection pressures → conserved psychological/neural predispositions → culturally and individually elaborated recurring motifs.
Pedigree collapse strengthens the “deep shared ancestry” part of that story. It illustrates why humanity isn’t composed of billions of separate genealogical lines stretching independently into antiquity. Our family trees become extraordinarily entangled.
But the crucial causal work would still be done by evolution and development, not pedigree collapse. Pedigree collapse tells us that ancestors are shared; natural selection and inheritance would have to explain why particular psychological dispositions became shared.
Robin Carhart-Harris
@RCarhartHarris
I more meant: learning about pedigree collapse (that we have a highly shared inheritance) and then contemplating how it might apply to archetypes i.e., shared psychological predispositions. Sure, it's an evo-devo thing...
-
Robin Carhart-Harris reposted
Nicholas Fabiano, MD
@NTFabiano
My colleague @RCarhartHarris (and senior author of this work) also has a book on the way.
He kindly sent me a galley copy and it’s an amazing read. -
Robin Carhart-Harris reposted
-
Robin Carhart-Harris
@RCarhartHarris
Make me think of the pivotal mental states model.
Robin Carhart-Harris
@RCarhartHarris
*Makes
-
Robin Carhart-Harris
@RCarhartHarris
Love this! Huge congrats to @KarlDeisseroth!
Stanford University
@Stanford
The most important briefings of the day.
Karl Deisseroth, professor of bioengineering and of psychiatry and behavioral sciences, shares the news of his Nobel Prize with his kids. -
Robin Carhart-Harris
@RCarhartHarris
My paper "The entropic brain today" is now nicely formatted as a PDF and published in the classic Neurology journal @Brain1878. Please check it and share it: doi.org/10.1093/brain/awag206
-
Robin Carhart-Harris
@RCarhartHarris
Check the fun read from @matthabusby ... Linked in this thread...
Robin Carhart-Harris
@RCarhartHarris
It's never that simple 😉 Nice work, Mattha. For folk interested in the latest academic paper on the entropic brain, see this: academic.oup.com/brain/article/149/10/3362/8704870 and for folk wanting something more accessible, for the general reader, definitely pre-order my book: lnk.to/HowPsychedelicsWork
-
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
It's never that simple 😉 Nice work, Mattha. For folk interested in the latest academic paper on the entropic brain, see this: academic.oup.com/brain/article/149/10/3362/8704870 and for folk wanting something more accessible, for the general reader, definitely pre-order my book: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
Check this out: psychedeliceducationpartnership.org/upep/
-
Robin Carhart-Harris
@RCarhartHarris
About to do this
-
Robin Carhart-Harris
@RCarhartHarris
In LA Friday night? Check this: www.laemmle.com/film/peaking
-
Robin Carhart-Harris
@RCarhartHarris
Grateful to have been included in this novel and interesting work. @danilobzdok pubmed.ncbi.nlm.nih.gov/42809102/
-
Robin Carhart-Harris
@RCarhartHarris
Our species has a protracted developmental period yet limited capacity for regeneration. We’re a slow cook species that’s hard to reverse once fully baked.
-
Robin Carhart-Harris
@RCarhartHarris
I’m excited to check this out! @michaelpollan @hubermanlab
Michael Pollan
@michaelpollan
My podcast with Andrew Huberman: What Humans, Animals & Plants Tell Us About Consciousness | Michael Pollan www.hubermanlab.com/episode/what-humans-animals-and-plant…
-
Robin Carhart-Harris
@RCarhartHarris
Still listed #1 hot new release. Pre-order here: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Another week, still #1 new release in my assigned category (Experimental Psychology)... Pre-order here: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Still #1. lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Around one month since pre-orders went live and still #1 new release, with around 1,100 pre-orders so far. Get yours? Write me if you wish to bulk order: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
Be excited, I know I am! www.esalen.org/workshops/how-psychedelics-work-a-journey-…
-
Robin Carhart-Harris
@RCarhartHarris
There are many problems with this argument/philosophy. It is both ethically and logically off.
Robin Carhart-Harris
@RCarhartHarris
If at first (or at all) you don't succeed (with blinding), get more aggressive... I disagree with this strategy... It is counter to patient centered research principles: jamanetwork.com/journals/jamapsychiatry/article-abstract/…
Robin Carhart-Harris
@RCarhartHarris
Consistent outcomes doesn’t imply consistent causation.
Robin Carhart-Harris
@RCarhartHarris
Highlighted text on right and column.
-
Robin Carhart-Harris
@RCarhartHarris
FDA guidance on adverse event reporting in psychedelic medicine trials verge on the absurd e.g., reporting sub-acute increases in kindness or less interest in alcohol use as AEs. #absurd #arbitrary
-
Robin Carhart-Harris
@RCarhartHarris
The argument for incomplete disclosure is also ethically flawed. It would be a procedure with no ecological/translational validity. Who knowingly dupes a patient ahead of a high-dose psychedelic... When does that happen in psychedelic-therapy?
Robin Carhart-Harris
@RCarhartHarris
If at first (or at all) you don't succeed (with blinding), get more aggressive... I disagree with this strategy... It is counter to patient centered research principles: jamanetwork.com/journals/jamapsychiatry/article-abstract/…
-
Robin Carhart-Harris
@RCarhartHarris
If at first (or at all) you don't succeed (with blinding), get more aggressive... I disagree with this strategy... It is counter to patient centered research principles: jamanetwork.com/journals/jamapsychiatry/article-abstract/…
Robin Carhart-Harris
@RCarhartHarris
Beating a dead horse springs to mind... Active comparator trials with a thorough approach to putative nonspecific causal variables (such as expectancy) & putative specific causal variables (eg biomarkers) is a smarter approach that doesn't deprioritize patient. @TheBorisLab
-
Robin Carhart-Harris
@RCarhartHarris
It’s easy to see overlaps between Carl Jung’s active imagination and heuristics for people going into a psychedelic journey: Jung’s active imagination was a deliberate technique for engaging with material arising from the unconscious while remaining awake and consciously attentive. It sits somewhere between dreaming, meditation, visualization, free association, and creative expression, but Jung regarded it as importantly different from simply fantasizing.
The basic procedure was roughly:
1. Begin with an emotionally charged inner event — perhaps a dream image, mood, bodily feeling, fantasy, or inexplicable emotion.
2. Turn attention toward it rather than analyzing it. You allow an image, scene, character, voice, or narrative to emerge spontaneously.
3. Let the imagery develop with minimal conscious direction. If a figure appears, for example, you don’t decide what it should do next; you watch what happens.
4. Participate in the scene. This is crucial. Rather than merely observing a fantasy, Jung encouraged a kind of dialogue with the figures or forces that emerge: asking them questions, responding to them, disagreeing with them, and seeing how they respond.
5. Give the experience concrete expression. This might mean writing the dialogue down, drawing or painting it, sculpting, moving/dancing, or otherwise externalizing what occurred.
6. Reflect on and integrate it afterward. The aim wasn’t to treat everything produced by the imagination as literally true. Conscious reflection had to engage with the unconscious material and work out what it might mean for one’s actual life.
Jung himself practiced something like this very intensely beginning around 1913. Much of the extraordinary imagery and dialogue recorded in The Black Books and subsequently transformed into The Red Book came out of these experiments.
One of the most interesting aspects of the technique is that Jung emphasized maintaining a tension between agency and surrender. Too much conscious control and you’re simply inventing a story; too little conscious participation and you’re essentially drifting into passive fantasy. Active imagination was supposed to create an encounter between the conscious ego and relatively autonomous unconscious processes.
That distinction is nicely captured by Jung’s description of allowing a fantasy to unfold while giving it one’s “whole attention” and observing how it changes of its own accord.
In more contemporary language, you could characterize it as a deliberately induced waking, immersive, internally generated experience in which top-down control is relaxed without being abandoned. The individual then interacts with the resulting material and subsequently integrates it. That makes it potentially quite relevant to ideas around psychedelic therapy, dreaming, and intrinsic psychological healing. -
Robin Carhart-Harris
@RCarhartHarris
Planning a psychedelic experience? If so, check this: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris describes the process of writing How Psychedelics W... youtu.be/t50wx5yDh1s via @YouTube
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Did you receive my newsletter? Yes? Did you like it? If so, suggest signing up to a friend? Missed out? Sign up here for next month's: carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
This amazing film is showing in a number of big US cities, coming very soon: peakingdocumentary.com
Robin Carhart-Harris
@RCarhartHarris
You can request a local showing here: peakingdocumentary.com/screenings
-
Robin Carhart-Harris
@RCarhartHarris
Formatted version of "The Entropic Brain Today" coming very soon...
-
Robin Carhart-Harris reposted
Tracy Kim Townsend, MD
@tracyktownsend
Thank you for gifting me an advance copy @RCarhartHarris
I have been eagerly awaiting this publication, and now I get to dig in early!
I can’t wait to apply what I learn to our practice at Meadow ✨🍄🟫✨ -
Robin Carhart-Harris
@RCarhartHarris
Another week, still #1 new release in my assigned category (Experimental Psychology)... Pre-order here: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Still #1. lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Around one month since pre-orders went live and still #1 new release, with around 1,100 pre-orders so far. Get yours? Write me if you wish to bulk order: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Same here. Will use this thread as a record.
-
Robin Carhart-Harris
@RCarhartHarris
Up the Cherries! #boscombe! #greatescape! #unbelievable! @afcbournemouth
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
Anil Seth
@anilkseth
An extraordinary @Nature paper has just landed from the lab of @Sergiu_P_Pasca at @Stanford - led by Konstantin Kaganovsky. They have found a way to create "xenocortical mice" which have ~92% of their cortex occupied by a cortical organoid derived from human stem cells. This human-derived cortical graft integrates deeply with the host nervous system, supporting organised neural activity and behaviour.
This study is a milestone in synthetic biology and chimera research. It has the potential to generate multiple medical breakthroughs by providing an enhanced biological model of human brain tissue that allows behavioural as well as neural and genetic assays.
The Stanford team have been exceptionally thorough and proactive in addressing ethical concerns that comes from this frontier work. But their pioneering work nonetheless raises many open questions: are the xenocortical mice conscious? Do they have any human-like properties of consciousness or cognition?
@NitaFarahany and I will be addressing some of these questions in a forthcoming commentary - where we'll also offer an ethically-informed roadmap to guide this important research as it progresses. In this context, "pacing the frontier" really does make sense 😉
Read the Stanford @nature paper here, and buckle up. It's wild. www.nature.com/articles/s41586-026-11032-2 -
Robin Carhart-Harris
@RCarhartHarris
Our recent paper "On the meaning of “plasticity” in neuroscience and mental health research and its relation to the action of psychedelic therapy" is now up on pubmed: pubmed.ncbi.nlm.nih.gov/42745840/
-
Robin Carhart-Harris reposted
New Scientist
@newscientist
LSD could be approved for anxiety in the US in 2027 www.newscientist.com/article/2589271-lsd-could-be-approve…
-
Robin Carhart-Harris
@RCarhartHarris
I was enjoying this until the speaker differentiated ancient beer from “psychoactives”. Why so? podcasts.apple.com/us/podcast/science-magazine-podcast/id…
-
Robin Carhart-Harris
@RCarhartHarris
Name dropped for being absent from fda meeting 😬 themicrodose.substack.com/p/report-from-the-fdas-hearing-…
Robin Carhart-Harris
@RCarhartHarris
Never been one for such meetings but glad to hear a microdose of the sensible things being raised. It’s one big experiment, for sure! I do hope it goes well 🤞
-
Robin Carhart-Harris
@RCarhartHarris
Some great lines here
-
Robin Carhart-Harris reposted
BryanRoth
@zenbrainest
@RCarhartHarris
Thanks!!! Signed!!!! -
Robin Carhart-Harris reposted
Paul Brown
@0xQuasark
🚨 TODAY: The FDA is about to spend 𝗙𝗢𝗨𝗥 𝗛𝗢𝗨𝗥𝗦 talking about psychedelics.
80 doctors, researchers, veterans & members of the public are about to decide the future of mental health in America.
𝗜𝘁 𝘀𝘁𝗮𝗿𝘁𝘀 𝗶𝗻 𝟰𝟱 𝗺𝗶𝗻𝘂𝘁𝗲𝘀.
𝘞𝘢𝘵𝘤𝘩 𝘭𝘪𝘷𝘦 𝘣𝘦𝘭𝘰𝘸 👇 -
Robin Carhart-Harris
@RCarhartHarris
Journos are gearing up for the big story: Psychedelics Are Medicines!
-
Robin Carhart-Harris
@RCarhartHarris
Sign up for my newsletter at carhartharrislab.com. New one coming very soon. Each week, I have an update on lab progress and you meet the lab, like here: youtu.be/WeD0p23B230
Robin Carhart-Harris
@RCarhartHarris
Just recorded the vid for the next episode... It was a fun one... Tell a friend to sign up: carhartharrislab.com
-
Robin Carhart-Harris reposted
Christian Angermayer
@C_Angermayer
Today, the acquisition of @ataibeckley, the psychedelics biotech company I founded in 2017, by @EliLillyandCo for up to $ 3.8 billion closed, marking one of the largest biotech acquisitions of the year - and the largest transaction in the history of the psychedelic sector.
When I first started contemplating bringing psychedelics back into mainstream medicine in 2014 - which ultimately resulted in founding $CMPS and, shortly after, $ATAI in 2017 - it was widely seen as a crazy idea with virtually no chance of success. Looking back today, it is almost funny how quickly collective memory changes. Today, psychedelic medicine feels almost inevitable. Back then, it was anything but.
And I am very proud and satisfied that I was able to play the role of one of the lead evangelists of this new era of mental health treatments.
I expressed all my thoughts and feelings in the blog post I published on the day the acquisition was announced. Feel free to revisit it: x.com/C_Angermayer/status/2077710248018936174
But there is one point I want to emphasize especially today: I believe Lilly is the best partner we could have wished for.
Not only is Lilly the largest and most successful pharmaceutical company in the world, but throughout every interaction - both before and after signing - they have demonstrated a deep understanding of the importance of bringing these valuable therapeutics back into the medical world and making them available to patients as soon as possible.
As I wrote in my blog post: Psychedelics needed an evangelist ten years ago. Now it is all about commercialization. And I cannot think of a better rollout machine than Eli Lilly.
And, as you have probably already guessed, selling AtaiBeckley certainly does NOT mean that I will be stepping away from neuroscience - and especially not from psychedelics. 😉
I believe more strongly than ever that the brain and our consciousness represent humanity’s final frontier - and one we need to explore with urgency, particularly as increasingly capable, and potentially sentient and conscious, AI systems move closer to reality.
I have some major news coming over the next few weeks, which may blow your mind, so make sure you follow me and turn on notifications if you don’t want to miss what’s next. -
Robin Carhart-Harris
@RCarhartHarris
Great episode: podcasts.apple.com/us/podcast/ancient-greece-declassified…
-
Robin Carhart-Harris
@RCarhartHarris
Reading and enjoying this. Is cellular dedifferentiation during regeneration analogous to the homeostatic recalibration we propose to be part of the therapeutic action of psychedelic-therapy?
Robin Carhart-Harris
@RCarhartHarris
What if psychedelics have an analogous action at the single cell level? Eg recalibrating the anatomy of a neuron after it is atrophied via stress induced insult.
Robin Carhart-Harris
@RCarhartHarris
Indeed, the principle could apply at multiple levels, single cell anatomy and function, population level activity, network organization etc etc
-
Robin Carhart-Harris
@RCarhartHarris
For thousands of years, Us modern humans have created culturally meaningful gists, akin to memes. The DMT entity is an example. The experience is a thing of primary consciousness but the construct/meaning is a thing of ego consciousness.
-
Robin Carhart-Harris
@RCarhartHarris
Webs of belief, rules, values, symbolism, and cultural meaning: things of ego consciousness that have only fully manifested within the last few tens of thousands of years. Curious that our (modern adult waking human quality of) consciousness be so young…
-
Robin Carhart-Harris reposted
Secretary Kennedy
@SecKennedy
I had a fascinating conversation with @w_bryan_hubbard about the future of psychedelic medicine on #thesecretarykennedypodcast.
Podcast episode out tomorrow. -
Robin Carhart-Harris
@RCarhartHarris
Do these charts reflect how this tx will look in the real-world? I sense they do. Once the rigmarole of blinding is dropped and the tx is given as per label, response (which will be a combo of psilo-specific x non-specific causation) is good.
Robin Carhart-Harris
@RCarhartHarris
'Convention' platforms the DBRCT as superior to the open-label design but the latter has some clear merits over the former.
-
Robin Carhart-Harris reposted
Psychedelic Vantage
@PsychedVantage
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
$CMPS
www.businesswire.com/news/home/20260909822109/en/Compass-… -
Robin Carhart-Harris
@RCarhartHarris
Limited time discounted pre-order deal for "How Psychedelics Work"
www.barnesandnoble.com/w/how-psychedelics-work-robin-carh… -
Robin Carhart-Harris reposted
Burton Tabaac
@burtontabaac
Robin really hit the mark with this one. The book is insightful & rich, yet I’m most in awe of the way in which the content flows.
Grateful for the advanced copy! Excited for the masses to get the chance to read it. Highly recommend. -
Robin Carhart-Harris reposted
Psilocybrain
@Psilocybrain
“How Psychedelics Work”
- Robin Carhart-Harris
@RCarhartHarris
Hardcover pre-orders here:
a.co/d/0iOm9jNb
Burton Tabaac
@burtontabaac
Robin really hit the mark with this one. The book is insightful & rich, yet I’m most in awe of the way in which the content flows.
Grateful for the advanced copy! Excited for the masses to get the chance to read it. Highly recommend. -
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
Eli Lilly Completes Acquisition of Psychedelic Drug Developer AtaiBeckley
This morning, AtaiBeckley shareholders approved the company’s acquisition by Eli Lilly in a deal valued at up to $3.8 billion. It marks the largest foray into the psychedelics field by an established pharmaceutical company to date.
The transaction was first announced in July after months of back and forth between the pair, who settled on terms that feature an upfront payment of $6.75 per share ($2.8 billion) plus up to $2.50 per share across three milestones that cover both the company’s lead intranasal 5-MeO-DMT candidate (BPL-003) as well as its DMT candidate, VLS-01.
At today’s special meeting, shareholders endorsed the deal. -
Robin Carhart-Harris
@RCarhartHarris
This happened: www.tradingview.com/news/urn:summary_document_transcript:…
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
The entropic brain effect is so robust in psychedelic EEG data... Here with DMT, exploring a range of metrics.
Robin Carhart-Harris
@RCarhartHarris
Grateful to be included here. Higher signal diversity, network dysregulation, and increased well-bei... www.sciencedirect.com/science/article/pii/S0006899326003926
-
Robin Carhart-Harris
@RCarhartHarris
Grateful to be included here. Higher signal diversity, network dysregulation, and increased well-bei... www.sciencedirect.com/science/article/pii/S0006899326003926
-
Robin Carhart-Harris reposted
AtaiBeckley Inc
@ataibeckley
AtaiBeckley has entered a definitive agreement to be acquired by @EliLillyandCo.
To our team, investigators, patients, and advocates: thank you!
Please refer to today’s full announcement for key information and cautionary statements: ir.ataibeckley.com/news-releases/news-release-details/lil… -
Robin Carhart-Harris
@RCarhartHarris
Profound little essay on us “humans.”
-
Robin Carhart-Harris
@RCarhartHarris
Excellent and important paper. Data from n = 346 & 24/26 Oregon service sites. 1-2% reporting harms and >90% benefits. Most saw value for money. Reflection of future.
-
Robin Carhart-Harris reposted
-
Robin Carhart-Harris reposted
The Law Enforcement Action Partnership (LEAP)
@PoliceForReform
‘New Zealand drugs regulator approves use of MDMA to treat severe PTSD’
www.theguardian.com/world/2026/sep/04/new-zealand-approve… -
Robin Carhart-Harris
@RCarhartHarris
Still #1. lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Around one month since pre-orders went live and still #1 new release, with around 1,100 pre-orders so far. Get yours? Write me if you wish to bulk order: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris reposted
Michael Pollan
@michaelpollan
This week's news in psychedelics: A federal report encourages states to prepare for FDA approval of psychedelics; Could THC help with the psychedelic blinding problem? themicrodose.substack.com/p/a-federal-report-encourages-s…
-
Robin Carhart-Harris
@RCarhartHarris
Never to young to educate one's developing self... 💖 pre-order to acquire merit for a blessed rebirth like this 😉 lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
*too
-
Robin Carhart-Harris
@RCarhartHarris
Inhaled 5-MeO-DMT vs Placebo in Treatment-Resistant Depression jamanetwork.com/journals/jamapsychiatry/fullarticle/2846834
Robin Carhart-Harris
@RCarhartHarris
"Mebufotenin" = a new name for me... Anyone else? Clearly a re-brand/spin thing...
Robin Carhart-Harris
@RCarhartHarris
Another trial exposing flawed nature of the double blind placebo controlled paradigm: www.researchgate.net/publication/413438376_Tales_of_the_u…
-
Robin Carhart-Harris
@RCarhartHarris
Decent coverage one of our recent papers here: youtu.be/3LKAFv7GYwQ
-
Robin Carhart-Harris
@RCarhartHarris
Interesting: www.frontiersin.org/journals/psychology/articles/10.3389/…
-
Robin Carhart-Harris
@RCarhartHarris
Now nicely formatted. Hope you enjoy. On the meaning of "Plasticity": www.frontiersin.org/journals/neuroscience/articles/10.338…
-
Robin Carhart-Harris
@RCarhartHarris
I need to spotlight this. Study in n = 4 cited as support for argument with 0 evidence base. It's a myth promoted by naysayers (leveraging an organized skepticism bias) that psychedelic medicine rests on an expectancy bias. There's no evidence for it. osf.io/preprints/psyarxiv/9w4mf_v1
Michael Ostacher, MD, MPH
@RecoveryDoctor
Important finding even if in just a handful of subjects. (Well, not even a handful.) It gives more evidence to the explanatory narrative that expectancy that produces the greatest effect in trials of psychedelic drugs for psychiatric conditions. @RCarhartHarris @Josh__Hardman
-
Robin Carhart-Harris
@RCarhartHarris
Rumour has it as parallel approval…
Paul F. Austin
@PaulAustin3w
Rumor is that MDMA could be approved by the FDA as early as October of this year
-
Robin Carhart-Harris
@RCarhartHarris
For your heart: podcasts.apple.com/us/podcast/heart-wisdom-with-jack-korn…
Robin Carhart-Harris
@RCarhartHarris
“‘Wow’ keeps us waked up”
-
Robin Carhart-Harris
@RCarhartHarris
How does psychedelic use relate to aspects of religiosity/spirituality? doi.org/10.1037/rel0000561
-
Robin Carhart-Harris reposted
Paul F. Austin
@PaulAustin3w
States Should Start Planning Now For FDA Approval Of Psychedelics, Federal Report Says
www.marijuanamoment.net/states-should-start-planning-now-… -
Robin Carhart-Harris
@RCarhartHarris
PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS academic.oup.com/neuro-oncology/article/27/Supplement_5/v…
Robin Carhart-Harris
@RCarhartHarris
It's important to note that it's proliferation once a particular tumor is there. It's not evidence that the psychedelic or 2A signaling is causative. FWIW, SSRIs likely do the same, and other drugs that can accelerate growth are still used e.g., benzos in childhood cancer.
-
Robin Carhart-Harris
@RCarhartHarris
Do we have an original mental health set point? Can psychedelic therapy catalyse a path back there? Is this felt as the inner healer?
-
Robin Carhart-Harris
@RCarhartHarris
Around one month since pre-orders went live and still #1 new release, with around 1,100 pre-orders so far. Get yours? Write me if you wish to bulk order: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
@drmichaellevin bioelectric interventionism cheats the canalization encoded by genes. Does entropic brain effect of psychedelics do something loosely analogous? Cheating the problematic canalization seeded by adversity?
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
AkashicNET×N2N🧠 Spiritual Science & Consciousness
@AkashicNET_org
“Science advances when feathers are ruffled.” 🪶🧠
Robin Carhart-Harris challenges what we mean by “plasticity”—proposing MR-P as a bridge from neural change to psychological flexibility and meaningful transformation.
#neuroscience #psychedelics #n2n
Robin Carhart-Harris
@RCarhartHarris
This is another theoretical paper that might ruffle some feathers. On the meaning of "plasticity": www.frontiersin.org/journals/neuroscience/articles/10.338…
-
Robin Carhart-Harris
@RCarhartHarris
This is another theoretical paper that might ruffle some feathers. On the meaning of "plasticity": www.frontiersin.org/journals/neuroscience/articles/10.338…
-
Robin Carhart-Harris
@RCarhartHarris
Fascinating new work here on low-dose psilocybin and brain function in autism: Distinct response of resting-state brain networks to psilocybin in autism www.medrxiv.org/content/10.64898/2026.08.19.26360794v1
-
Robin Carhart-Harris
@RCarhartHarris
I hit 100: scholar.google.com/citations?user=7_MD_w0AAAAJ&hl=en
Robin Carhart-Harris
@RCarhartHarris
H-index. 100 papers with 100 or more citations. 👍
-
Robin Carhart-Harris
@RCarhartHarris
Join 6.5K others and Subscribe to my lab’s newsletter here: carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
This should ruffle some feathers... osf.io/preprints/psyarxiv/9w4mf_v1
Robin Carhart-Harris
@RCarhartHarris
@ExistWell @sdpnayak @GLoewinger @psybalazs @TheBorisLab Hey guys, would be curious for your thoughts...
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Please click the link below if you're interested in participating in this study. Please share it if you think you know someone who might be interested. ucsf.co1.qualtrics.com/jfe/form/SV_4JIpSiCBL4igWtU
-
Robin Carhart-Harris
@RCarhartHarris
Enjoying listening to @drmichaellevin Levin. Does the “faster and finer” brain activity induced by psychedelics liberate an ordinarily comparatively latent agential capacity, relevant to the feeling of intrinsic healing (esp in supportive contexts) ie “the inner healer”?
Robin Carhart-Harris
@RCarhartHarris
The entropic activity catalyses its ability to get back to some place..
Robin Carhart-Harris
@RCarhartHarris
Catalyses the brain’s ability to get back there.
-
Robin Carhart-Harris
@RCarhartHarris
Over 1000 pre-orders so far, thanks to @Gonzogardner and other kind and curious souls 🙏🙏🙏 -hoping to carry the momentum through… Imagine if we do make the illustrious bestseller list… 🤞✨lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
How do I look? Good? Pre-order me? lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
Context matters more the harder you trip… 👌
Adeel Razi
@adeelrazi
Our new paper in @Nature is now out.
Psychedelics don’t simply disorder the brain. Using fMRI, EEG and AI in 62 psychedelic-naive adults, we found hidden, context-sensitive organisation beneath the apparent chaos -- strongest in people reporting more positive, profound experiences and a reduced sense of separation from the world.
The paper: www.nature.com/articles/s41586-026-10910-z
Huge congratulations to @dpsyc42 who led from the front, @novelli_leo and @MKhajehnejad were exceptional in performing highly sophisticated and complex data analyses and thanks the whole @ConnectPsi team and collaborators.
Our explainer: theconversation.com/new-research-shows-how-psychedelics-r…
Data descriptor: www.nature.com/articles/s41597-026-07312-1
ML model (TAVRNN): www.nature.com/articles/s42003-026-10721-y
Fully open-access dataset: openneuro.org/datasets/ds006110/versions/1.2.0
Code for processing and cleaning data: github.com/razilab/psiconnect
@matthewdgreaves Tmarin Barta, @ManaBiabani, @SidChop, @anilkseth, @RCarhartHarris, @FredBarrettPhD, @KatrinPreller, @gary_egan
@turnerinstitute @MonashPsych, @Monash_FMNHS, @MonashUni @CIFAR_News -
Robin Carhart-Harris reposted
Adeel Razi
@adeelrazi
Our new paper in @Nature is now out.
Psychedelics don’t simply disorder the brain. Using fMRI, EEG and AI in 62 psychedelic-naive adults, we found hidden, context-sensitive organisation beneath the apparent chaos -- strongest in people reporting more positive, profound experiences and a reduced sense of separation from the world.
The paper: www.nature.com/articles/s41586-026-10910-z
Huge congratulations to @dpsyc42 who led from the front, @novelli_leo and @MKhajehnejad were exceptional in performing highly sophisticated and complex data analyses and thanks the whole @ConnectPsi team and collaborators.
Our explainer: theconversation.com/new-research-shows-how-psychedelics-r…
Data descriptor: www.nature.com/articles/s41597-026-07312-1
ML model (TAVRNN): www.nature.com/articles/s42003-026-10721-y
Fully open-access dataset: openneuro.org/datasets/ds006110/versions/1.2.0
Code for processing and cleaning data: github.com/razilab/psiconnect
@matthewdgreaves Tmarin Barta, @ManaBiabani, @SidChop, @anilkseth, @RCarhartHarris, @FredBarrettPhD, @KatrinPreller, @gary_egan
@turnerinstitute @MonashPsych, @Monash_FMNHS, @MonashUni @CIFAR_News -
Robin Carhart-Harris
@RCarhartHarris
Very grateful to be included in this stellar work, just published in @Nature . Very well done, Devon, Adeel and co! www.nature.com/articles/s41586-026-10910-z
Robin Carhart-Harris
@RCarhartHarris
Study found that context matters more the harder you trip….
-
Robin Carhart-Harris
@RCarhartHarris
More ego dissolution, more sensitivity to context…
Devon Stoliker
@dpsyc42
7/16 Context alignment tracked experiential quality. Accuracy was most strongly associated with positively felt self- and boundary-dissolving dimensions, less strongly with sensory–hallucinogenic effects, and minimally or negatively with anxiety and impaired cognition.
-
Robin Carhart-Harris reposted
Devon Stoliker
@dpsyc42
1/16 Our work is now published in @Nature.
The psychedelic brain is often described as desynchronised or entropically disordered. That is true, but incomplete.
Beneath the apparent disorder, we found structured brain activity aligned with context.
www.nature.com/articles/s41586-026-10910-z -
Robin Carhart-Harris
@RCarhartHarris
24 mins, trippy and true: youtu.be/c8iFtaltX-s
-
Robin Carhart-Harris
@RCarhartHarris
How do I look? Good? Pre-order me? lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
It's geometry at base: www.nature.com/articles/s41586-023-06098-1
-
Robin Carhart-Harris
@RCarhartHarris
Watch out for another psychedelic human neuroimaging paper in @Nature publishing tomorrow...
-
Robin Carhart-Harris
@RCarhartHarris
Thoughts on this? What would a 5-MeO-DMT factor look like? What about an ibogaine one? Items need to specific to drug vs generic across drugs e.g., "I experienced an awesome brightness" (5-MeO-DMT) = good; vs "My consciousness felt altered" (generic) = bad.
Robin Carhart-Harris
@RCarhartHarris
And the paper itself: journals.sagepub.com/doi/10.1177/02698811261464986
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Nice to see this up on pubmed. Big up Avery Ostrand and co! pubmed.ncbi.nlm.nih.gov/42605589/
-
Robin Carhart-Harris
@RCarhartHarris
General advice on dealing with academic trolls?
Robin Carhart-Harris
@RCarhartHarris
I don't mean fair criticsim. I do mean a provocative troll type...
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
If it turns out not to be (fair), I’ll let you know and post my response somewhere (eg my newsletter) in full/unedited.
Robin Carhart-Harris
@RCarhartHarris
The key question, of course, is: is this trolling alone, or an opportunity to clarify some misunderstandings? I chose the latter.
-
Robin Carhart-Harris
@RCarhartHarris
When you ask “why?” Long enough eventually you end up in the math department… youtu.be/EdEqgCOSx7E
-
Robin Carhart-Harris
@RCarhartHarris
Another media report on our psilocybin therapy anorexia trial: Could Psilocybin Help Treat Anorexia? A Small Clinical Trial Suggests the Psychedelic May Make Patients More Open to Recovery www.smithsonianmag.com/science-nature/could-psilocybin-he… via @smithsonianmag
-
Robin Carhart-Harris
@RCarhartHarris
We need >1K pre-orders to be competitive for any kind of bestseller status on release. This elusive accomplishment is very hard for anyone, let alone a debut author, but good to aim high. Our start so far is where we need it though. 451 pre-orders... lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
lnk.to/howpsychedelicswork Pre-order here, please. This book will help people stay safe and find benefit. Help me max it’s impact via a successful pre-order campaign. #mybro
Robin Carhart-Harris
@RCarhartHarris
We need >1K pre-orders to be competitive for any kind of bestseller status on public release. The elusive bestseller accomplishment is very hard for anyone, let alone debut authors, but good to aim high. Our start so far is where we need it though. 451 pre-orders...
-
Robin Carhart-Harris
@RCarhartHarris
Grateful to contribute and passionate to advocate for this: www.nature.com/articles/s44184-026-00234-1 @ElliotMarseille
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
All I'd add is that the existing scales are pretty good e.g., WHO-5 and WEMWBS. We just need folk to brave enough to use them as primaries and the powers that be to be brave enough to respect their meaningfulness.
-
Robin Carhart-Harris
@RCarhartHarris
This looks important: Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer: Cell www.cell.com/cell/fulltext/S0092-8674(26)00826-3
-
Robin Carhart-Harris
@RCarhartHarris
Family fun. #galleys #proofs #howpsychedelicswork @ScribnerBooks lnk.to/howpsychedelicswork
-
Robin Carhart-Harris
@RCarhartHarris
Well over 300 US/Canada pre-order sales after last check. If curious to pre-order, please go for it! Why? = price is held and boosts marketing/impact… see link in original post…
Robin Carhart-Harris
@RCarhartHarris
Pre-order my new book: www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
Robin Carhart-Harris
@RCarhartHarris
And still top of new releases…
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
341 pre-orders. Might create a thermometer to show target no. of pre-orders ahead of release.
-
Robin Carhart-Harris
@RCarhartHarris
Sanctuary and Soul. London.
-
Robin Carhart-Harris
@RCarhartHarris
Meeting with publishers of “How Psychedelics Work”, Ebury, Penguin Random House. Want it to best-sell? Pre-order here: lnk.to/HowPsychedelicsWork
Robin Carhart-Harris
@RCarhartHarris
Apparently the threshold no. of pre-orders to compete for a Sunday Times bestseller upon public release is 1000 for the UK and rest of the world... Will let you know how it's doing. No stats for UK+ yet...
-
Robin Carhart-Harris
@RCarhartHarris
A thorough article on our trial of psilocybin therapy for anorexia: www.scientificamerican.com/article/psilocybin-could-kick-…
Robin Carhart-Harris
@RCarhartHarris
I dedicate a chapter to this trial and topic in my forthcoming book. See my bio for pre-order links.
-
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
"It’s almost stupefying to think of this compound, which was so obscure as recently as fifteen years ago, now being subject to the largest deal in the psychedelics space and being bought by the world’s biggest pharma company. That is so rich and strange, and I think it indicates how kind of ‘up for grabs’ and unpredictable the future of psychedelics is." - Kimon de Greef
Read the full conversation on our website: psychedelicalpha.com/news/from-sonora-to-big-pharma-kimon… -
Robin Carhart-Harris
@RCarhartHarris
Deep blinding is symptomatic of an over attachment to a flawed paradigm.
-
Robin Carhart-Harris
@RCarhartHarris
It is a category conflation to regard the psychedelic experience as an expectancy confound. Expectancy is a prior belief.
Robin Carhart-Harris
@RCarhartHarris
It is a mistake to conflate expectancy with (what are far more likely to be) direct tx effects.
Robin Carhart-Harris
@RCarhartHarris
The longitudinal assessment of expectancy would tee up this category error, (wrongly) treating an effect as a cause, and reasoning by consequence as a result.
-
Robin Carhart-Harris
@RCarhartHarris
Please pre-order my book. Updated link: lnk.to/HowPsychedelicsWork
-
Robin Carhart-Harris
@RCarhartHarris
First and second edition bookmarks. The new version (black) has an updated QR code that links to the pre-order site.
Robin Carhart-Harris
@RCarhartHarris
This link is best if you're outside of the US: amzn.eu/d/08QCKoqY
-
Robin Carhart-Harris reposted
nature
@Nature
Could 'biophotons' represent a new signalling mechanism in cells? Or be used to diagnose disease?
go.nature.com/45cQzEF -
Robin Carhart-Harris reposted
Michael Levin
@drmichaellevin
Congratulations @niroshajmurugan and everyone else whose work was covered - a really important field! It deserves much more focus.
Nirosha J. Murugan
@niroshajmurugan
You emit light.
Expanding biology beyond molecules allows us to consider another layer of life: how energy, including light, may reflect and perhaps help coordinate biological activity.
Thank you to @JoMarchant and @Nature for featuring our work alongside other leaders in the field, and for opening a broader conversation about what might be possible, the tools we must build, and the next generation of scientists we must train.
Now, we have the opportunity to determine what the light of life is telling us. -
Robin Carhart-Harris
@RCarhartHarris
What an exciting start! Gonna enjoy this! urldefense.com/v3/__https://www.mdpi.com/2077-1444/17/7/7…$
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Insight is pregnant with action, like potential energy.
Robin Carhart-Harris
@RCarhartHarris
I can report: it is excellent. Fascinating stuff. Halfway through.
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Pre-order my new book: www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
Robin Carhart-Harris
@RCarhartHarris
Nice to see it’s on a bestseller list already… www.amazon.com/Best-Sellers-Medical-Experimental-Psycholo…
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
*Please* pre-order my book (is a much better way of saying it!) - please excuse the bad manners there.
-
Robin Carhart-Harris
@RCarhartHarris
Early sales figures are very good. Thanks to those who’ve pre-ordered. Please “tell the others”- pre-orders help energize the publicity investment efforts that will come. I do feel my book will help many people.
Robin Carhart-Harris
@RCarhartHarris
Pre-order my new book: www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
-
Robin Carhart-Harris
@RCarhartHarris
Speaking at Exeter Uni today. Reconnecting with my dear friend @LeorRoseman @UniofExeter
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Kevin Keegan brought a lot of joy to my family. Probably the first footballer I remember being talked about. The Entertainers was a special time in the history of Newcastle United and the premier league. He loved attacking football. Respect. Rest in Peace. 🫡 🏴 ⚽️
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
My new book is now available to pre-order on Penguin too. Ebury (Penguin Random House) have publishing rights for the UK and rest of the world. www.penguin.co.uk/books/462658/how-psychedelics-work-by-c…
Robin Carhart-Harris
@RCarhartHarris
Pre-order my new book: www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
-
Robin Carhart-Harris
@RCarhartHarris
Argentina have disgraced themselves today. Well done Spain! 🇪🇸 🇪🇺🌎 🏆
Robin Carhart-Harris
@RCarhartHarris
No shots on goal for well over 100 mins of football! More red cards than shots (and should have been more!) - so much cheating, so many afters. Justice for football.
-
Robin Carhart-Harris
@RCarhartHarris
People are going to enjoy this one. More entropic funny business. Psychedelics breaking chunked stuff up into smaller bits. Greater number of smaller brain spirals moving more entropically.
-
Robin Carhart-Harris
@RCarhartHarris
Reading this and not yet done but wondering: why are psychoanalysts so shy of psychedelic phenomenology? The gap they don’t fill with psychology gets filled with metaphysical speculation.
Robin Carhart-Harris
@RCarhartHarris
I’m thinking of work like this but there are lots of relevant constructs eg projection, transference, archetypes galore: www.amazon.com/dp/0691018227?lv=shuf&channelId=520&plpRed…
Robin Carhart-Harris
@RCarhartHarris
And platonic forms (very relevant to Jung)…
Robin Carhart-Harris
@RCarhartHarris
Also (not psychoanalytic necessarily) but priming eg as per day residue impacting dream content.
Robin Carhart-Harris
@RCarhartHarris
Isn’t it Occam’s razor to hypothesize that inter-individual consistencies in the content forms of “entity encounter” are due to a shared psychology?
Robin Carhart-Harris
@RCarhartHarris
There’s a missing premise problem. Big Leaps from eg math to obscure metaphysical conclusions. Why the skipping over of psychology- which is epistemically far closer to the territory (phenomenology)?
Robin Carhart-Harris
@RCarhartHarris
This problem creates non-sequiturs- ie because of x math, entity encounters occur because we get to perceive the complex dynamics of other conscious agents that are usually hidden.
Robin Carhart-Harris
@RCarhartHarris
It’s akin to god in the gaps: because things are weird, god did it. Here it’s: because DMT experiences are so vivid, rich, weird, compelling, we must gain access to a hyper-dimensional reality ordinarily hidden to our perceptual apparatus. Or “entities are really out there”.
Robin Carhart-Harris
@RCarhartHarris
See what I mean?
Robin Carhart-Harris
@RCarhartHarris
Is the mathiness window dressing? Propping up a weak analogy, missing premise or inferential leap.
Robin Carhart-Harris
@RCarhartHarris
If they were to reply “the ordinarily imperceptible conscious agent(s) become manifest from the ordinarily inaccessible mind, (encoded biologically, of course)” - then I would walk back my issue with this work.
Robin Carhart-Harris
@RCarhartHarris
But I’m not sure they would as the article begins with a straw-manning of cognitive neuroscience and the invoking of the hard problem of consciousness. The usual stuff…
Robin Carhart-Harris
@RCarhartHarris
Here’s the article (and how it ends). Despite the final paragraph first sentence, they do seem to suggest the entities are actual external conscious agents (hence my beef): osf.io/preprints/psyarxiv/8qvgy_v2
-
Robin Carhart-Harris
@RCarhartHarris
Very cool findings here: rdcu.be/fuoxd
-
Robin Carhart-Harris
@RCarhartHarris
My book, coming soon. Checking the very final proofs. www.amazon.com/How-Psychedelics-Work-Hidden-Power/dp/1668…
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
James W. Sanders
@JWSanders_
Very happy to share that our paper, “Micro-phenomenology of immersion and perceived presences under DMT,” is now published in Neuroscience of Consciousness @NeuroConsc
academic.oup.com/nc/article/2026/1/niag015/8733941 -
Robin Carhart-Harris
@RCarhartHarris
David Baddiel
@Baddiel
Thank you to this poster, who may just have a tiny bit of insight into how to win at the highest level of sport.
Martina Navratilova
@Martina
At the top level, playing not to lose loses most of the time..
David Baddiel
@Baddiel
Here’s @KuperSimon, @FT, unsuprisingly correct.
-
Robin Carhart-Harris
@RCarhartHarris
Psychedelics Trials and Outcomes—A Closer Look jamanetwork.com/journals/jamapsychiatry/fullarticle/2851371 Thanks to @JD_Rosenblat . There was more we could say but this is something. More to come in terms of how to improve psychedelic trial design to address functional unblinding.
Robin Carhart-Harris
@RCarhartHarris
The pre-trail withdrawal of traditional antidepressant (TAD) then reinstatement of a TAD (sometimes the same TAD!) is scandalous. Huge course of bias.
Robin Carhart-Harris
@RCarhartHarris
And this was only done for Ps who were TAD responders! How the hell did they get away with that!?
Robin Carhart-Harris
@RCarhartHarris
*source
-
Robin Carhart-Harris
@RCarhartHarris
Big up James Sanders and Chris Timmermann! Fascinating topic: @neurodelia: pubmed.ncbi.nlm.nih.gov/42454183/
-
Robin Carhart-Harris reposted
Jeremy Rudy
@JeremyRudy
Today was better than Christmas.
Psychedelic Alpha
@Psyched_Alpha
Today has brought a flurry of federal announcements regarding psychedelics, with the FDA (Food and Drug Administration), VA (Department of Veterans Affairs), ARPA-H (Advanced Research Projects Agency for Health), NIDA (National Institute on Drug Abuse), and HRSA (Health Resources and Services Administration) all going on the record in support of psychedelics-related efforts.
In our latest, we provide a brief recap: psychedelicalpha.com/news/keeping-up-with-the-feds-from-f… -
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Coming home to back count bin face.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Remember, if you plan a psychedelic experience, consider taking our survey beforehand: www.carhartharrislab.com/studies
-
Robin Carhart-Harris
@RCarhartHarris
Fascinating: podcasts.apple.com/us/podcast/the-rest-is-history/id15377… 🇺🇸 🇬🇧
-
Robin Carhart-Harris reposted
Martijn Arns
@Brainclinics
New $CMPS Psilocybin Ph3 readout: The question is not so much 'if' it works, but more 'how' it should be clinically implemented with repeat dosing.
Remission rate in TRD increased from 7% to 18% at wk6 with 2 doses of COMP360 (vs 1 dose) and impressive durable response up-to 26 weeks suggesting added efficacy of repeat dosing.
Should non-remitters be dosed 3-4 times? And what could 'psychotherapy-assisted' add to the mix?
Impressive sample size at N=581 and highly resistant TRD sample is important context for remission rates. -
Robin Carhart-Harris
@RCarhartHarris
Another replication of expectancy failing to predict response here: www.cambridge.org/core/journals/the-british-journal-of-ps…
Robin Carhart-Harris
@RCarhartHarris
Hoping people stop parroting the myth that the causal action of psychedelic therapy is some kind of placebo-related self-fulfilling prophecy. The evidence simply fails to support it, again and again.
-
Robin Carhart-Harris
@RCarhartHarris
Nice coverage by @imperialcollege here. Includes the caveats while not neglecting the positives. Hard to emphasize enough the challenge of treating anorexia. Was this our hardest trial? Maybe... www.imperial.ac.uk/news/articles/2026/psilocybin-therapy-…
-
Robin Carhart-Harris
@RCarhartHarris
Please pre-order my book today. One for you, one or two for a loved one? www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
Robin Carhart-Harris
@RCarhartHarris
Please pre-order my book today. One for you, one or two for a loved one? www.simonandschuster.com/books/How-Psychedelics-Work/Robi…
-
Robin Carhart-Harris
@RCarhartHarris
Watch out for a very significant new paper on psilocybin therapy for anorexia publishing tomorrow....
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Psilocybin therapy for adult females with anorexia nervosa: pilot study | The British Journal of Psychiatry | Cambridge Core - www.cambridge.org/core/journals/the-british-journal-of-ps…
Robin Carhart-Harris
@RCarhartHarris
“When using the ‘community norm’ as an indicator of ‘remission’, six participants (28.6%) at the final visit, ten participants (47.6%) at the 3-month follow-up and eight participants (38.1%) at the 6-month follow-up were within this zone [for remission].”
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
All Fútbol MX 🇲🇽
@AllFutbolMX
Mexico fans congratulating England fans after yesterday’s match at the Estadio Azteca.
This is what football is all about. 🏴
Respect. ❤️🤝🏼✨ -
Robin Carhart-Harris reposted
Lloyd Canfield
@LloydCanfield
A message to the people of Mexico. From an English journalist on behalf of England fans. 🏴🇲🇽
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Loved Mexicans before, love them still. Great passion for the game. Great people. 🇲🇽 ⚽️
Henry Winter
@henrywinter
I've covered hundreds of England internationals. That was one of the greatest. For performance in and out of possession, for the stage and the competition. Quick video celebration from the Azteca. #mexeng
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
So proud of the boys! 🦁 🦁 🦁
-
Robin Carhart-Harris
@RCarhartHarris
Watching England 🏴 in Esalen California 🐻! Sat in my italia 90 jersey, Enjoying telling my 🇺🇸 friends the story about mdma changing the culture in 🏴 in those years and the world in motion song 🌎
Robin Carhart-Harris
@RCarhartHarris
“Sing E for England”
Robin Carhart-Harris
@RCarhartHarris
“Love’s got the world in motion” 🎶
-
Robin Carhart-Harris
@RCarhartHarris
Brain Entropy and 5-MeO-DMT: What Neuroscience Is Revealing youtu.be/VGoBu-gtCL8 via @YouTube
-
Robin Carhart-Harris
@RCarhartHarris
My book can be pre-ordered now... I will share the link...
-
Robin Carhart-Harris reposted
HLTCO
@HLTCO
All of the England fans properly cheering when Michael Harris catches a routine fly-ball midway through this. 😂
This media couldn't be displayed. See it on the original post.
HLTCO
@HLTCO
“Baseball’s coming home again, with Michael Harris!”
Lloyd Canfield
@LloydCanfield
England fans have chosen a random baseball player, Michael Harris of the Atlanta Braves, to support more than anyone else at the baseball after beating DR Congo 😭🫱🏼🫲🏾🏴⚾️
And it’s absolutely class 👏This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Of course. Michael Harris, my father, my brother, England adores.
Lloyd Canfield
@LloydCanfield
England fans have chosen a random baseball player, Michael Harris of the Atlanta Braves, to support more than anyone else at the baseball after beating DR Congo 😭🫱🏼🫲🏾🏴⚾️
And it’s absolutely class 👏This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Big up, Lorenzo and co! onlinelibrary.wiley.com/doi/10.1002/hbm.70596
-
Robin Carhart-Harris
@RCarhartHarris
I was joining in from California! What a brave performance by both teams. Best of sport. Fantastic!
Barstool Gambling
@stoolgambling
England celebrating the win with Wonderwall is incredible
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Gives me chills! Wow! What a game we created for the world! 🏴 🌍 ⚽️
-
Robin Carhart-Harris
@RCarhartHarris
Stone wall penalty!
-
Robin Carhart-Harris
@RCarhartHarris
I hope the $ making ketamine clinics adhere to guidelines for good psychedelic therapy when they can give psilocybin therapy.
Robin Carhart-Harris
@RCarhartHarris
Bookmark this for posterity, it's a thing.
-
Robin Carhart-Harris reposted
Dugout prasanth📽️🏏
@DieHardFanOfTh4
Will forever be grateful for that iconic Ashes knock.
One of the greatest innings cricket has ever witnessed. Thank you, Ben Stokes, for the unforgettable memories.
Thank you, Stokesy. 🫡🏏This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Me to 🇺🇸 barmaid in LA: “you had Scotland in here”- her “yeah but there’s something special about England, they’re the best” 🏴
Robin Carhart-Harris
@RCarhartHarris
And no, there was no option to tip… was genuine 🤷 👍 🏴
-
Robin Carhart-Harris
@RCarhartHarris
Why does the gazza crying in 1990 semi-final t-shirt not exist any more? It was everywhere that year! 🤷♂️ 🏴 🦁 🦁 🦁
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Is it because it was a long time ago?
Robin Carhart-Harris
@RCarhartHarris
Does anybody even know what I’m talking about? 🤷♂️
-
Robin Carhart-Harris
@RCarhartHarris
In hollwood for premier of “Peaking”
-
Robin Carhart-Harris
@RCarhartHarris
Writing the acknowledgments for my book. Sad to learn that my first psychology tutor passed in 2020. Laurie Baynes. He was a lovely man and a great tutor. 🙏rip.ie/death-notice/laurie-baynes-cork-clonakilty-398724
-
Robin Carhart-Harris
@RCarhartHarris
England’s goat
The Football Tavern
@TavernFootball
Where have the years gone?
30 years ago today Paul John Gascoigne sent Colin Hendry for an ice cream.
What a day. What a tournament. What a summer.
Memories to last a lifetime
Robin Carhart-Harris
@RCarhartHarris
Inspired my love of the game like no other #19
-
Robin Carhart-Harris
@RCarhartHarris
I’m English but hats off 🏴!
James Melville 🚜
@JamesMelville
It has been reported that a 125-decibel sound level was recorded at the Scotland v Haiti game during the pre match anthem singing of Flower of Scotland - the loudest ever noise level at a World Cup match. 🏴
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
My review of evidence for "The entropic brain" is now available unformatted. Formatted version coming soon. pubmed.ncbi.nlm.nih.gov/42266156/
-
Robin Carhart-Harris
@RCarhartHarris
Enjoyed this. Especially the final part on that platonic forms (latent perennial patterns) and how bioelectrical fields are ideal for finding them. youtu.be/6mU5nN5nlLA
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Abstract up on pubmed. Paper itself coming soon. pubmed.ncbi.nlm.nih.gov/42266156/
-
Robin Carhart-Harris
@RCarhartHarris
Love this page on the brain by Carl Sagan.
-
Robin Carhart-Harris
@RCarhartHarris
This was fun to be involved with. Big up Jonas, Michael and co! pubmed.ncbi.nlm.nih.gov/42255330/
-
Robin Carhart-Harris
@RCarhartHarris
Hope folk are enjoying my lab’s newsletter this month. We now feature one of our studies each month and have lab members describe. Seems people are loving the new format so far… sign up via carhartharrislab.com
Robin Carhart-Harris
@RCarhartHarris
Looks a bit like this…
And Here’s that link for those that are intrigued and wonder what they get if they sign up… m.youtube.com/watch?v=WeD0p23B230&ra=m
Robin Carhart-Harris
@RCarhartHarris
Obviously it’s quite a bit longer than that! Just the open part shown… Sign up here (5K+ have)… carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
This is good
-
Robin Carhart-Harris
@RCarhartHarris
This was crazy. Burying failed SSRI trials. Published findings positive in ~100% vs 50% if they included the buried ones. Imagine reaction to bias like this psychedelic trials?! Tmk, no buried trials in psychedelic medicine. maryland.ccproject.com/wp-content/uploads/sites/3/2014/02…
Robin Carhart-Harris
@RCarhartHarris
Standards of transparency in psychedelic trials far outshine corrupt SSRI trials… as I recently discovered when I examined those open label SSRI trials…
-
Robin Carhart-Harris
@RCarhartHarris
Plato’s republic unpacked here. The structural harmony is interesting. I see parallels with ego shoes going naturally back on after tripping: podcasts.apple.com/us/podcast/ancient-greece-declassified…
Robin Carhart-Harris
@RCarhartHarris
Versus the chaos/anarchy of the trip itself.
-
Robin Carhart-Harris
@RCarhartHarris
Courtesy of @UCSF_AndrewPenn Dr Paul Daley and the spirit of @DrAShulgin #shulginfarm
-
Robin Carhart-Harris
@RCarhartHarris
Very much enjoyed chatting with Sam Harris: youtu.be/R3nSgtsuiY4
-
Robin Carhart-Harris
@RCarhartHarris
Just found this. journals.plos.org/plosmedicine/article?id=10.1371/journal… It is now the 5th replication of no relationship between pre-tx expectancy and response to psychedelic therapy. Please be aware of the expectancy-myth re the action of psychedelic therapy. It has no direct evidence base.
Robin Carhart-Harris
@RCarhartHarris
The MBSR+PAP column is the one to examine. No correlation between expectancy and response. 5th time that's been observed now in independent psychedelic therapy trials. The null must now be a v weighty prior. I wonder if someone could formalize the Bayes here...
Robin Carhart-Harris
@RCarhartHarris
Page 7 of the supplementary appendix. The r value is 0.04! p = 0.9! Numerically, that's another inversion of the general rule i.e. with psychedelic therapy, those with higher expectations actually do (numerically) worse! We found the same in our 2024 work...
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Absence of evidence is evidence of absence when evidence would be expected if the hypothesis were true.
-
Robin Carhart-Harris
@RCarhartHarris
If physical healing process is given a psychedelic therapy linked mental parallel... are these phases resonant with after glow (proliferation) and prolonged integration (remodeling)?
Robin Carhart-Harris
@RCarhartHarris
And this might be the 'storm' of the trip itself...
-
Robin Carhart-Harris
@RCarhartHarris
This from this: pubmed.ncbi.nlm.nih.gov/33852780/
-
Robin Carhart-Harris
@RCarhartHarris
Absence of evidence is evidence of absence when evidence would be expected if the hypothesis were true.
Robin Carhart-Harris
@RCarhartHarris
This is the more rationale phrasing of *that phrase* - it always struck me as logically problematic. Like the “you can’t prove a negative” phrase… that’s also problematic - for the same reason.
-
Robin Carhart-Harris
@RCarhartHarris
Local to #sanfrancisco #bayarea? Planning your first trip? Plan for it to be shrooms? If yes to all, check out this new study we call "Bay Area Brains" or "BABS." BABS is a sub-project under our broader project known as "CANOPY." General sign up happens via the link below or scan one of the QR codes in the flyer. ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
This is good.
-
Robin Carhart-Harris
@RCarhartHarris
Still brings goosebumps... I was there... afc bournemouth great escape pt 2 youtu.be/uVXiSJ7ZYpk via @YouTube
Robin Carhart-Harris
@RCarhartHarris
3-0 vs Shrewsbury, kept us in 3rd tier of English football and helped us survive as a club after facing bankruptcy and being bailed out by the club’s fans.
Robin Carhart-Harris
@RCarhartHarris
I was 14 years old.
-
Robin Carhart-Harris
@RCarhartHarris
In psychedelic medicine (& beyond), It is common to conflate nonspecific tx or context effects with expectancy effects. Yet the latter can function as a quite independent/orthogonal variable, as I will soon show.
-
Robin Carhart-Harris
@RCarhartHarris
I doubt we’ll ever top this. What a season! 🍒🇪🇺
-
Robin Carhart-Harris
@RCarhartHarris
Yo! #bayarea massive! Check out this new Carhart-Harris Lab/UCSF psychedelic study and whether you might be eligible to take part: ucsf.co1.qualtrics.com/jfe/form/SV_3Kx0ICR0KzTOULA You must be local to the #sanfrancisco Bay Area.
Robin Carhart-Harris
@RCarhartHarris
Beautiful art is by Allyson Grey.
-
Robin Carhart-Harris
@RCarhartHarris
Dear Anyone and Everyone, Planning a trip anywhere and anytime in any way? Check out this Carhart-Harris Lab/UCSF survey study: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
This will splash in the classic journal 'Brain' soon...
-
Robin Carhart-Harris
@RCarhartHarris
Was a delight hanging with the legend that is @zenbrainest yesterday. zendudest.substack.com/p/whats-up-with-ibogaine?r=g3vpk&t…
-
Robin Carhart-Harris
@RCarhartHarris
Very exciting pivot point in history... The first FDA approved psychedelic therapy... This year?!
Psychedelic Alpha
@Psyched_Alpha
Compass Pathways' Chief Medical Officer Guy Goodwin spoke at the American Psychiatric Association's annual meeting earlier this week in San Francisco.
There, he shared that the company's synthetic psilocybin candidate, COMP360, could be on the market for treatment-resistant depression as soon as late 2026 or early 2027.
"We're at a very exciting stage for a company", Goodwin said, "but I think more importantly, a very important turning point for the whole field; we're going to have psychedelics to use, and it's going to be very exciting for you as practitioners." -
Robin Carhart-Harris
@RCarhartHarris
This is amazing: podcasts.apple.com/us/podcast/the-rest-is-history/id15377…
-
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
“This underscores the need to have therapists available with experience in dealing with emerging and frightening material, which is common in volunteers with a history of trauma. All the unresolved issues come bubbling to the surface under the influence of the psychedelic.” - Scott T. Aaronson
Read the full conversation on our website: psychedelicalpha.com/news/psilocybin-for-chronic-suicidal… -
Robin Carhart-Harris reposted
Richard Keys
@richardajkeys
Scandlous @afcbournemouth Absolute disgrace. I guess you’re looking for someone to take Bournemouth to the next level? There isn’t a ‘next level’ This is it. There is no more. I remember Charlton wanting to do the same. How did that work out?
-
Robin Carhart-Harris
@RCarhartHarris
Gamma carries 'entropic brain' phenomena. In @elife: Spectrally and temporally resolved estimation of neural signal diversity doi.org/10.7554/eLife.88683.1
-
Robin Carhart-Harris reposted
AFC Bournemouth 🍒
@afcbournemouth
The next incredible chapter of this football club is written ❤️
We’ll be in Europe for the first time in our 127-year history next season 🌎
On to Sunday for one final push to find out which competition 💪 -
Robin Carhart-Harris reposted
Back Of The Net 🍒
@afcbpodcast
The highs are higher because the lows were lower.
Congratulations Arsenal, but AFC Bournemouth are in EUROPE! 😍🍒❤️ -
Robin Carhart-Harris reposted
enjoying the moment 🍒
@thepeakofafcb
HISTORY AWAITS.
A NIGHT FOR THE AGES.
TOGETHER, ANYTHING IS POSSIBLE!!!
UP THE CHERRIES 🍒
#afcb #utciad -
Robin Carhart-Harris
@RCarhartHarris
🍒!
Robin Carhart-Harris
@RCarhartHarris
UTC!
-
Robin Carhart-Harris
@RCarhartHarris
The (~100 min) insight re healthcare approval for psychedelics and associated up-scale in use prevalence having an indirect impact on human spirituality is an astute one. My forthcoming book 'How Psychedelics Work' ends with a reflection on this.
Robin Carhart-Harris
@RCarhartHarris
Charles Raison, MD - Professor of Human Ecology and Psychiatry Universit... www.youtube.com/live/vvtW_mtsnt4 via @YouTube
-
Robin Carhart-Harris
@RCarhartHarris
Charles Raison, MD - Professor of Human Ecology and Psychiatry Universit... www.youtube.com/live/vvtW_mtsnt4 via @YouTube
Robin Carhart-Harris
@RCarhartHarris
Chuck is humble but he has one of the best reads you could hear on how all of this will play out re approvals and post-approval...
Robin Carhart-Harris
@RCarhartHarris
~50 mins in...
Robin Carhart-Harris
@RCarhartHarris
"It's not going to get easier, it's going to get wilder."
-
Robin Carhart-Harris
@RCarhartHarris
More psychological prep, better outcomes: Psychological Therapy Quantity and Depressive Symptoms in Psychedelic Therapy jamanetwork.com/journals/jamanetworkopen/fullarticle/2844126
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Overly cynical or legitimate concerns? I lean to the latter. open.substack.com/pub/ecstaticintegration/p/therapists-on…
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
There’s always been a tension between science and therapy, some of this comes from the sentiments of the latter. There is a balance that can be found but the tension remains.
Robin Carhart-Harris
@RCarhartHarris
Part of the problem here stems from issues with the lycos review and a problematic messaging re “therapy”- as in, “play it down.”- Dangerous.
-
Robin Carhart-Harris
@RCarhartHarris
Reading this and reminded of the absurdity of hard behaviourism and its influence.
-
Robin Carhart-Harris
@RCarhartHarris
Just seen third replication of lack of expectancy to response prediction in psychedelic medicine trial. That’s 3/3 of my last 3 trials. Why won’t other teams test and report on this? See 2 new trials coming soon that replicate null seen here. Red is null. www.cambridge.org/core/journals/psychological-medicine/ar…
Robin Carhart-Harris
@RCarhartHarris
Broken down: contrary to a far too popular myth, there is no evidence for expectancy effects with psilocybin therapy.
Robin Carhart-Harris
@RCarhartHarris
Context moderation and expectancy effects are not the same thing.
-
Robin Carhart-Harris
@RCarhartHarris
On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy osf.io/preprints/psyarxiv/wzh7b_v1 via @OsfFramework
-
Robin Carhart-Harris
@RCarhartHarris
Curious. Opposite DTI/FA findings to those we recently published on. Region specific? Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment: Cell Reports Medicine www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26…
-
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
Psychedelic researcher @RCarhartHarris spoke to us about a new study published in Nature Communications that looks at brain changes after first psilocybin use.
-
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Puts a bit of perspective on things…
-
Robin Carhart-Harris
@RCarhartHarris
Psilocybin in the Treatment of Cocaine Use Disorder jamanetwork.com/journals/jamanetworkopen/fullarticle/2848757
-
Robin Carhart-Harris reposted
Josh Hardman
@Josh__Hardman
I spoke with Peter Hendricks about his fascinating psilocybin for cocaine use disorder study, out today.
Aside from the impressively representative patient population and positive result, there was also a report of spontaneous orgasm!
Full interview (no paywall)...
Psychedelic Alpha
@Psyched_Alpha
Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making
psychedelicalpha.com/news/psilocybin-for-cocaine-use-diso… -
Robin Carhart-Harris
@RCarhartHarris
Very cool work here: www.nature.com/articles/s42003-026-09912-4
-
Robin Carhart-Harris
@RCarhartHarris
One Dose of Psilocybin Changes the Human Brain www.ucsf.edu/news/2026/05/431866/one-dose-psilocybin-chan…
-
Robin Carhart-Harris
@RCarhartHarris
I do hope this doesn’t get overlooked as the access train gathers momentum… it’s proven extremely hard to win federal funding for research like this (zero success rate so far 🤷♂️) NIMH @MAHA_Institute arpa-h
-
Robin Carhart-Harris
@RCarhartHarris
What Happens in the Brain When “Psychedelic Virgins” Trip for the First Time nautil.us/what-happens-in-the-brain-when-psychedelic-virg…
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
After turning on to psychedelics, some say they are never the same again— Why? —No one knows... until now...? www.nature.com/articles/s41467-026-71962-3
-
Robin Carhart-Harris
@RCarhartHarris
Another good one here. www.scientificamerican.com/article/does-a-psychedelic-tri…
Robin Carhart-Harris
@RCarhartHarris
And this, so true:
-
Robin Carhart-Harris
@RCarhartHarris
One dose of psilocybin changes the human brain, leading to higher entropy medicalxpress.com/news/2026-05-dose-psilocybin-human-brai… via @medical_xpress
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
After turning on to psychedelics, some say they are never the same again— Why? —No one knows... until now...? www.nature.com/articles/s41467-026-71962-3
-
Robin Carhart-Harris
@RCarhartHarris
Science gets closer to understanding how a psychedelic trip changes the brain www.nbcnews.com/health/health-news/science-gets-closer-un… via @nbcnews
-
Robin Carhart-Harris
@RCarhartHarris
Effects of psychedelic use on authoritarian attitudes revisited - Otto Simonsson, Taylor Lyons, Joseph Marks, Hannes Kettner, Leor Roseman, Eline Haijen, Mendel Kaelen, Robin Carhart-Harris, 2026 journals.sagepub.com/doi/10.1177/02698811261443677?url_ve…
Robin Carhart-Harris
@RCarhartHarris
Could be a floor effect but this sums it up pretty well...
Robin Carhart-Harris
@RCarhartHarris
p.s. another paper dropping tomorrow... Watch out for that...
Robin Carhart-Harris
@RCarhartHarris
Big up Otto for driving this!
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
Very big paper dropping this Tuesday… watch this space… tell your gran… tell your neighbours… “Human brain changes after first psychedelic use” - Nature Communications…
-
Robin Carhart-Harris
@RCarhartHarris
Very big paper dropping this Tuesday… watch this space… tell your gran… tell your neighbours… “Human brain changes after first psychedelic use” - Nature Communications…
-
Robin Carhart-Harris reposted
Martin Picard
@MitoPsychoBio
The idea that sequencing more genomes would lead to better medicine and better health was a good hypothesis in 2000. But 26 years later, evidence has quite convincingly disproven that hypothesis.
The answer to most common chronic illnesses that plague us isn't written in genes. Personalized medicine likely cannot come from sequences of nucleic acids. There is more to life's dynamic nature.
Why do we cling onto that hypothesis/dogma like it is truth.
Max Marchione
@maxmarchione
The cost of sequencing a human genome dropped from $100M to less than $100 in about 25 years.
That's a million-fold decrease, which outpaces even Moore's Law.
We're about to enter the era of personalized medicine. -
Robin Carhart-Harris
@RCarhartHarris
Been getting v nice feedback and a slew of new sign ups to my newsletter. Next edition coming very soon and it will be a goodie! Very rich! So much going on! Spread the word & sign up here: carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
Just as the cosmos is rich beyond measure, so is the mind.
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
Tim Ferriss
@tferriss
New and free documentary on psychedelics, awareness, and meditation, exec produced by Sam Harris.
-
Robin Carhart-Harris
@RCarhartHarris
My recent chat with Sam Harris. Check it! www.wakingup.com/course/CO09D0D
-
Robin Carhart-Harris reposted
No Way Out - The OODA Loop & Flow Podcast
@NoWayOutcast
Sam Harris (@MakingSenseHQ) just dropped Unraveling the Dream.
Beautiful film on the science of psychedelics — featuring the work of @RCarhartHarris, Karl Friston, and @anilkseth.
Watch it before next Tuesday.
On April 28, No Way Out drops our episode with Karl Friston — where we go deeper on all of it.
👇 -
Robin Carhart-Harris reposted
Todd
@toddmshapiro
Echoing our exact thoughts for 6 years. 👏 This is just unreal for @joerogan to single-handedly expedite progress, ending stigmas and helping with access which will have such a positive impact on so many. The future looks magical. Thank you.
-
Robin Carhart-Harris reposted
Stephen Zerfas
@stephen_zerfas
10/10 recommend. Psychedelics and advanced meditation, both as experiences and as social movements, share a lot in common. Jake does a terrific job making accessible some of the more complex neuroscience ideas underlying both, and in the process, suggests new ways to think about what and how we are.
Jake Orthwein
@JakeOrthwein
🆕📺 THE FILM IS OUT!!! (YT Link Below)
UNRAVELING THE DREAM: Psychedelics, Awakening, and the Brain
I couldn’t be more excited to finally get to share with all of you! -
Robin Carhart-Harris
@RCarhartHarris
Been applying to her office and others (eg welcome trust, nimh, arpa) for years asking to test/demonstrate that this isn’t magical thinking or snake oil. Glad to see things might change.
Psychedelic Alpha
@Psyched_Alpha
Speaking at the signing of a psychedelics-focused executive order on Saturday, NIDA Director Nora Volkow shared how her view of psychedelic therapy has changed over the past decade.
More: psychedelicalpha.com/news/president-trump-signs-executive… -
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
📼 5-minute Overview: The Psychedelics Executive Order
Our Editor @Josh__Hardman walks you through the executive order that President Trump signed this morning.This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
“If these turn out to be as good as people are saying, it’s going to have a tremendous impact on this country and other countries too.” - President Trump
More: psychedelicalpha.com/news/president-trump-signs-executive… -
Robin Carhart-Harris reposted
The White House
@WhiteHouse
President Trump will always stand with America's veterans. This executive order allows for accelerated treatment to benefit all Americans with serious mental health conditions, a landmark effort for those in need. 🇺🇸❤️
-
Robin Carhart-Harris reposted
Jake Orthwein
@JakeOrthwein
🆕📺 THE FILM IS OUT!!! (YT Link Below)
UNRAVELING THE DREAM: Psychedelics, Awakening, and the Brain
I couldn’t be more excited to finally get to share with all of you! -
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
Jake Orthwein
@JakeOrthwein
Still the 19th in the relevant timezone! But you can set a notification for the premiere here: youtu.be/r5KRnstXYUg
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Planning a trip of any variety? Check this. ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris reposted
Patrick Heizer
@PatrickHeizer
The "capture rate" is the percentage of people who try a substance that end up addicted.
Alcohol, cocaine, and methamphetamine all have similar capture rates, with ~20% of users developing an addiction.
Should we be advocating for nuance around cocaine and meth consumption?
Derek Thompson
@DKThomp
One of the things I found really frustrating about public health guidance during the pandemic was that the public wasn't trusted with nuance, so the communication was often over-torqued.
I think health communicators should trust their audiences with nuance.
"Friends, stop drinking alcohol. Not cut back. Eliminate." isnt' really nuance. It's absolutism. You're offering a pragmatic defense of absolutism, and it's smart to be pragmatic, but I'd prefer we just be honest: Alcohol is a delicious bit of extremely mild cellular poison and having too much of it is really bad in the long run but having a little of it won't kill you.
Everything in the realm of diet circles the issue of moderation. Chronic caloric surplus leads to obesity. Severe caloric deficit can lead to death. I'd prefer we attempt to articulate the principle of moderation in alcohol, too -
Robin Carhart-Harris
@RCarhartHarris
“If there’s no consciousness, what’s the proper scale?” M Pollan.
-
Robin Carhart-Harris
@RCarhartHarris
Big up Eric et al for driving this: Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin www.tandfonline.com/eprint/WFDTHB8JADF57Z7MFSJY/full?targ…
-
Robin Carhart-Harris
@RCarhartHarris
Papers coming soon... 1) Human brain changes after first psilocybin use (Nature Comms), 2) Psilocybin for Anorexia (BJ Psych), 3) Psilocybin for Fibromyalgia (EEG biomarkers)—tbc, 4) The Entropic Brain Today (Brain)... And more!
Robin Carhart-Harris
@RCarhartHarris
It's been a good year for the lab... carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
This is awesome! Check it out!
Jake Orthwein
@JakeOrthwein
📺 🆕 OFFICIAL TRAILER!! Coming April 20th!
This media couldn't be displayed. See it on the original post.This post is unavailable. See it on X. -
Robin Carhart-Harris reposted
nature
@Nature
Hundreds of scans hint at how substances such as psilocybin, LSD and ayahuasca alter connections between key areas of the brain
go.nature.com/4miIANM -
Robin Carhart-Harris
@RCarhartHarris
Mega analysis of psychedelic fMRI studies: www.nationalgeographic.com/health/article/psychedelics-br… via @NatGeo @MGirnNeuro
Robin Carhart-Harris
@RCarhartHarris
A very familiar profile of effects seen when pooling across teams and studies...
Robin Carhart-Harris
@RCarhartHarris
Big up @MGirnNeuro and @danilobzdok for leading the way!
Robin Carhart-Harris
@RCarhartHarris
Network disintegration and desegregation. High-level transmodal cx/networks especially impacted.
Robin Carhart-Harris
@RCarhartHarris
Check out this #pubmed article through @unboundmedicine Prime: "An international mega-analysis of psychedelic drug effects on brain circuit function." ubmed.com/m/41942645
-
Robin Carhart-Harris
@RCarhartHarris
Figure S4 here still intrigues me today... www.nejm.org/doi/suppl/10.1056/NEJMoa2032994/suppl_file/n…
Robin Carhart-Harris
@RCarhartHarris
What does it suggest? That the SSRI, escitalopram fails to improve emotional functioning in depression and may blunt certain things e.g., ability to cry, whereas psilocybin therapy is more deeply restorative.
Robin Carhart-Harris
@RCarhartHarris
Having observed effects like this explains why I'm passionate about the misrepresentation of the comparative action of psilocybin therapy vs traditional antidepressant drug treatments. There's an important truth that people could miss is allowed to be misled.
-
Robin Carhart-Harris
@RCarhartHarris
Bryan's is a v curious case for the REBUS model. I may well be wrong, but my sense is that Bryan is reflecting on the alternative view (to the one he may have canalized) i.e., that dying (when the time is 'right') is acceptable. I'll check in on this. It's v curious.
Bryan Johnson
@bryan_johnson
The strongest case against me is that I've built an identity around not dying so completely that I can no longer evaluate evidence that dying might be acceptable. If survival is the only framework, I have no way to test whether survival is worth it.
-
Robin Carhart-Harris
@RCarhartHarris
“Consciousness is how humans do sentience” M Pollan
-
Robin Carhart-Harris reposted
Science girl
@sciencegirl
The BBC “spaghetti tree” hoax is one of the most famous April Fools’ pranks, broadcast on 1 April 1957 on Panorama, narrated by Richard Dimbleby
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
There will be some big papers on this topic publishing within the next few weeks and months... Oh yes, and then a book... which will be on this and much more...
Evan McGloughlin
@evan_mcgl
"Brain entropy is the best biomarker for consciousness. It's the simplest map for the territory."
"When there's more disorder, to a point, you could say there's more consciousness. There's an expansion of consciousness. And that's the psychedelic state."
"I thought that decreased brain activity with psychedelics was a pretty consistent replicated finding. No. It's a popular myth."
One of my favourite episodes I've ever done. With the remarkable @RCarhartHarris ⬇️This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
“Drugs don’t heal people, people do” - Martin Picard. 😊@MitoPsychoBio
Martin Picard
@MitoPsychoBio
Very unlikely that a step change in health will come from drugs. Drugs don't heal. They mask deeper issues.
Would love to see Demis' and Deep Mind's genius be put towards understanding what keeps us healthy in the first place--so we don't need to rely on partial drug fixes.
Ian Miles Cheong
@ianmiles
Demis Hassabis: If you know the structure of a protein, the real question becomes—where will your drug bind, and what will it actually do?
That’s where the next wave of AI comes in. Not just predicting structures, but modeling interactions, outcomes, and real biological impact. At Isomorphic Labs, this is already happening—with 17 active drug programs and partnerships with giants like Eli Lilly and Novartis. The goal? Scale that to 100.
This is a fundamental shift in how medicine gets built. Instead of slow, expensive trial-and-error in wet labs, AI allows researchers to run thousands of hypotheses in silico—hundreds to thousands of times more efficiently. The wet lab becomes validation, not exploration.
Drug discovery is turning into a computational problem. Faster cycles, smarter predictions, and potentially massive breakthroughs in human health. -
Robin Carhart-Harris
@RCarhartHarris
Nearly 5K subscribe to my monthly newsletter. Sign up at the bottom here. Next one coming soon! www.carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
Anyone have access? pubmed.ncbi.nlm.nih.gov/30840787/
-
Robin Carhart-Harris reposted
Franklin King MD
@KingFranklinIV
New preprint by @trpwolff challenging methods and conclusions in the recent Goodwin et al paper that found no association between psilocybin outcomes and therapeutic alliance: osf.io/preprints/psyarxiv/8s7xk_v1
-
Robin Carhart-Harris reposted
Evan McGloughlin
@evan_mcgl
"Brain entropy is the best biomarker for consciousness. It's the simplest map for the territory."
"When there's more disorder, to a point, you could say there's more consciousness. There's an expansion of consciousness. And that's the psychedelic state."
"I thought that decreased brain activity with psychedelics was a pretty consistent replicated finding. No. It's a popular myth."
One of my favourite episodes I've ever done. With the remarkable @RCarhartHarris ⬇️This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Of course someone thought of it...
-
Robin Carhart-Harris reposted
5MEO MOVIE
@5MEOMOVIE
We released this a few years ago. It was difficult to get traction from main stream media but @Graham__Hancock @michaelpollan @RCarhartHarris the late Amanda Feidling from @BeckleyResearch and @NeoPharmaco from Forbes watched and reviewed it for us. @bryan_johnson might like?
This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Ps - FWIW, I can’t recall claiming that “world’s most cited” thing… I don’t think it’s true. Maybe per annum but not overall.
Robin Carhart-Harris
@RCarhartHarris
2h+ deep dive into my research here. Thanks to @MightyPursuit
-
Robin Carhart-Harris reposted
David W. Lawrence
@davidwlawrence1
Excited to share a preprint of "The Allostatic Reset Model (ARM) of Psychedelic Action":Psychedelics drive a staged, multisystem stress-response process progressing from acute perturbation to adaptive recalibration & resilience. @RCarhartHarris @NTFabiano osf.io/preprints/psyarxiv/hxegk_v1
-
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris Is Mapping the Mind Using Psychedelics doubleblindmag.com/robin-carhart-harris-is-mapping-the-mi…
Robin Carhart-Harris
@RCarhartHarris
Gratitude to @_webbwright for this generous profile.
-
Robin Carhart-Harris
@RCarhartHarris
Pleased to be included in this work. Emotional breakthrough as a strong predictor of response (again): pubmed.ncbi.nlm.nih.gov/41881122/
-
Robin Carhart-Harris
@RCarhartHarris
Here it is again. Same systematic bias to favor response to the "tested" drug. Talk about confirmation bias!
Robin Carhart-Harris
@RCarhartHarris
I'll share others in this thread. Here: pubmed.ncbi.nlm.nih.gov/10440523/ Ps could washout of TADs for 2-wks and then enter. This could explain the high baseline HAM-D of 25. Just 2-wk washout before TAD will bias response, abating discontinuation effects.
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
Robin Carhart-Harris
@RCarhartHarris
They really made sure with this one!
-
Robin Carhart-Harris
@RCarhartHarris
Here it is again. TAD nonresponders excluded.
Robin Carhart-Harris
@RCarhartHarris
I'll share others in this thread. Here: pubmed.ncbi.nlm.nih.gov/10440523/ Ps could washout of TADs for 2-wks and then enter. This could explain the high baseline HAM-D of 25. Just 2-wk washout before TAD will bias response, abating discontinuation effects.
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
Robin Carhart-Harris
@RCarhartHarris
Also, this and other open label TAD trials allow flexible dosing by response and tolerability that aren't a feature of psychedelic DBRCTs. Flexible dosing would be nice but that's a pragmatic design. It's different. Another deck stack.
-
Robin Carhart-Harris
@RCarhartHarris
When we published our H2H in @NEJM Ian Jordan raised an excellent letter re SSRI discontinuation & how it might impact response. We looked & found he was right. Those who discontinued SSRIs and went back on (escitalopram) did far better than those who were med free coming in.
Robin Carhart-Harris
@RCarhartHarris
The difference was massive. Now, if you run an open label TAD trial and bias things by washing out of TADs before going back on, clearly it will cause the same biased response. And stack the deck further by excluding TAD nonresponders & hey presto, what do you have? ...
Robin Carhart-Harris
@RCarhartHarris
Surprising good responses to TADs... IT'S A FIX.
-
Robin Carhart-Harris
@RCarhartHarris
Here it is again. Amazing how researchers could get away with this back then. Regular systematic bias of excluding TAD nonresponders. Also note another thing inconsistent with core psychedelic trial period i.e., that Ps were allowed to continue psychotherapy outside the trial.
Robin Carhart-Harris
@RCarhartHarris
I'll share others in this thread. Here: pubmed.ncbi.nlm.nih.gov/10440523/ Ps could washout of TADs for 2-wks and then enter. This could explain the high baseline HAM-D of 25. Just 2-wk washout before TAD will bias response, abating discontinuation effects.
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
Robin Carhart-Harris
@RCarhartHarris
Also, the brief pretrial washout of TADs (1-2 wk) will inflate baseline severity (discontinuation effect) then drop it when you get your TADs back in your system........
-
Robin Carhart-Harris
@RCarhartHarris
Here there's both exclusion of TAD nonresponders and a pragmatic design element with flexible dosing to suit response and side-effects. Clearly inconsistent with the design of the psychedelic therapy trials. More systematic bias to TADs.
Robin Carhart-Harris
@RCarhartHarris
I'll share others in this thread. Here: pubmed.ncbi.nlm.nih.gov/10440523/ Ps could washout of TADs for 2-wks and then enter. This could explain the high baseline HAM-D of 25. Just 2-wk washout before TAD will bias response, abating discontinuation effects.
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
-
Robin Carhart-Harris
@RCarhartHarris
More serious problems identified. Blatant systematic bias within these trials. Only recruiting Ps known to be responders to the TAD. And then they go into open label trial!
Robin Carhart-Harris
@RCarhartHarris
I'll share others in this thread. Here: pubmed.ncbi.nlm.nih.gov/10440523/ Ps could washout of TADs for 2-wks and then enter. This could explain the high baseline HAM-D of 25. Just 2-wk washout before TAD will bias response, abating discontinuation effects.
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
Robin Carhart-Harris
@RCarhartHarris
Developers of escitalopram involved (Lundbeck). 2nd of 2 coauthors here.
-
Robin Carhart-Harris
@RCarhartHarris
I'll share others in this thread. Here: pubmed.ncbi.nlm.nih.gov/10440523/ Ps could washout of TADs for 2-wks and then enter. This could explain the high baseline HAM-D of 25. Just 2-wk washout before TAD will bias response, abating discontinuation effects.
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
-
Robin Carhart-Harris
@RCarhartHarris
Anyone have a PDF of this? Perhaps there isn't a digital copy... This one showed an impressive -16.6 HAM-D drop with 8 weeks of escitalopram. It would be good to know their methodology. pubmed.ncbi.nlm.nih.gov/18178988/
-
Robin Carhart-Harris
@RCarhartHarris
Anyone have access to a PDF of this? pubmed.ncbi.nlm.nih.gov/11816867/
-
Robin Carhart-Harris
@RCarhartHarris
See this for just 1 of the TAD trials from recent @psybalazs and @QuantPsychiatry comparative analysis. 1 of several deck stacks favoring TADs. This trial reported a surprising -15.2 HAM-D drop with venlafaxine. Not so surprising when you look closer... www.tandfonline.com/doi/epdf/10.1080/13651500310001446?ne…
-
Robin Carhart-Harris reposted
Bryan Johnson
@bryan_johnson
This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer.
The 27mg dose opened up what felt like pure consciousness and intelligence. A majestic reveal of existence itself. In all its incomprehensible glory and majesty. It is impossible to explain with words. Whatever you imagine, multiply it by 1,000 and then add infinite width and depth and dimensions.
But entrance was not granted without prerequisite. Existence demanded that I submit. That I say yes; without attachment and without condition. Yes to existence; yes to the dissolution of self; yes to release control; yes, to all.
My ego registered the ask and panicked. It wanted control. It was desperate for control. It pleaded to escape from the torrent of light and essence that threatened to rip my sanity into chards. The urge to eject was overwhelming. Terror thundered throughout my mind and body.
It took everything within me to release. I overcame and was treated with bliss that defies imagination. A euphoria colored with perfect harmony of all things. An orchestra of essence washed over me and swept me up in dance. It was home. The highest aspiration of intelligent life. For some reason, stored and tucked away as the ultimate prize.
A single concept emerged in omnipresence: we cannot grok the preciousness of our existence. Yet it is everything we’ve ever wanted and more. The state we long for without knowing it exists. This caused me great pain and heartache.
A swell of loyalty and devotion emerged inside me, pledging allegiance to existence. To become a warrior and caretaker of life on earth. To protect at any cost the candle of consciousness that has miraculously emerged in this part of the galaxy.
What awaits will wipe all your tears, soothe all your sorrows, and infinitely exceed your wants. -
Robin Carhart-Harris reposted
-
Robin Carhart-Harris
@RCarhartHarris
A dumb question (but I'll ask anyway): In a psilocybin fMRI study, is it possible to use MRS to measure brain regional concentrations of psilocin?
Robin Carhart-Harris
@RCarhartHarris
Beyond measured GABA and glutamate concentrations, what other neurotransmitters can MRS be used to index/measure?
-
Robin Carhart-Harris
@RCarhartHarris
Big up Claudio! Much gratitude for the inclusion: pubmed.ncbi.nlm.nih.gov/41863255/
-
Robin Carhart-Harris
@RCarhartHarris
I can’t let this point go w’out comment. @psybalazs is first author on work that showed expectancy effects between PAT and a TAD are not uniform. They were operative for the TAD but not PAT. Why isn’t that cited?!
Robin Carhart-Harris
@RCarhartHarris
He also knows that there are 3 (or more) replications of the lack of expectancy to response rship for PAT about to publish. So why this narrative about more of an expectancy effect with PAT?! The discussion feels consistently biased to me. Feels like spin.
Robin Carhart-Harris
@RCarhartHarris
Blue is response to SSRI predicted by pre trial expectancy. No such relationship applies for PAT. Szigeti et al. 24. www.cambridge.org/core/journals/psychological-medicine/ar…
-
Robin Carhart-Harris
@RCarhartHarris
It follows that if TADs are biased by expectancy, Open Label trials will show better outcomes than blinded. Further, if expectancy is not a strong driver of response to psychedelics, then blinding shouldn’t matter as much. This is what they found.
-
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
I suspect they’ve all bought the non psychedelic psychedelic pill. After all, it would $ much more simply. It’s a wishful story. Good if true. But a naked emperor?
Robin Carhart-Harris
@RCarhartHarris
If it’s way “they” say it is, it has v little to do with psychedelic therapy and its core action. It’s more likely to be a “me too” TAD or microdosing in disguise.
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
But alas, the challenge is great to fund this line of work. My line of work is not An easy ally of the system… evidently….
-
Robin Carhart-Harris
@RCarhartHarris
Fools and idiots doesn’t feel like right or skillful speech, as the Buddhists would say, but if experience is so impt (I agree it is) why work on engineering it out?
BryanRoth
@zenbrainest
Anyone who has experienced psychedelics knows that the effect is 'unforgettable'.
Only a 'fool or an idiot' would deny that this affects how one answers structured interview questions.
As well, there are undeniable benefits of 'one dose' for a *minority* of patients.
In my travels I frequently encounter vets with PTSD whose symptoms have been, essentially, ameliorated. But....this is not due to 'one dose of psilocybin'. Instead, the typical story is that they had:
MULTIPLE PSYCHEDELIC-ASSISTED THERAPEUTIC SESSIONS,
frequently with a variety of psychedelics and non-psychedelics like ibogaine.
Sure, you can do all sorts of imaginative post-hoc statistical analyses and "you will affirm your priors."
But...don't abandon your common sense.
BTW: 'back in the day' I ran/was an investigator for many, many psychiatric drug trials (I ran an inpatient research ward at CWRU).Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Expectancy seems not to predict response but relational and experiential factors do. This is the latest science.
Robin Carhart-Harris
@RCarhartHarris
Psychedelic therapy is a different paradigm to TADs, and thankfully so.
Robin Carhart-Harris
@RCarhartHarris
Those developing non psychedelic psychedelics are rowing against this. It’s not novel, it’s the same chronic drugging of problems.
-
Robin Carhart-Harris
@RCarhartHarris
This is key. It speaks to the deck stack I’ve been highlighting.
Robin Carhart-Harris
@RCarhartHarris
It’s more the weight of the evidence than an opinion. 4 psychedelic trials measuring expectancy (xp), all show No xp effect (xpe) on outcomes. Response to Traditional ADs (TADs) will be biased by a well known xpe for TADs if the trials are open label.
-
Robin Carhart-Harris
@RCarhartHarris
Here's a provocative position: I don't believe in the importance of blinding integrity.
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
I can answer "no, the evidence is not good and strong."
Robin Carhart-Harris
@RCarhartHarris
And this matters.
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
It’s more the weight of the evidence than an opinion. 4 psychedelic trials measuring expectancy (xp), all show No xp effect (xpe) on outcomes. Response to Traditional ADs (TADs) will be biased by a well known xpe for TADs if the trials are open label.
-
Robin Carhart-Harris
@RCarhartHarris
DMT increasing high freq gamma oscillations: Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N-Dimethyltryptamine in Rats www.jneurosci.org/content/46/5/e0742242025
-
Robin Carhart-Harris
@RCarhartHarris
I'd like to emphasize that this is the stark difference between our trial and the recent comparative analysis (CA). Ours was a DBRCT trial with several controls and comprehensive standardization. The CA wasn't an experiment at all. It was a post hoc selection of data with some..
Robin Carhart-Harris
@RCarhartHarris
Yes. 6 weeks and one day of daily placebo capsules if Ps went into the psilocybin arm.
Robin Carhart-Harris
@RCarhartHarris
transformation of data eg into a single scale (HAM-D) which is known to be one of the least sensitive to change. I wonder if that played a role too. I see a lot of limitations with the work. Most stark is the obvious inconsistency between trial types for 1 group (psilocybin) vs
Robin Carhart-Harris
@RCarhartHarris
the other (traditional ADs). As I've said, that looks to me like an obvious deck stack. It's rationalized by functional unblinding but I don't find that justification compelling. The differences in procedure are far starker than the similarities.
-
Post not available here, view on XPost not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Yes. 6 weeks and one day of daily placebo capsules if Ps went into the psilocybin arm.
-
Robin Carhart-Harris
@RCarhartHarris
But one set of trials (TAD) were open label and other set of trials (psychedelic) included impt elements of experimental control, procedures like randomization and blinding. Does functional unblinding mid-session justify treating these trials as procedurally equivalent? No.
Robert Y. Chen
@therealRYC
I think the pushback on a negative result framing highlights my point - that a core message of the analysis is that we have been fooling ourselves about the effect size on traditional placebo controlled studies.
If we ran an open label trial of psychedelics and a SSRI and found no difference in effect but massive differences in dosing frequency , side effects, etc, that would be a negative result based on the primary endpoint. But many positives can come out from a negative result.
That’s I guess my point - people assume negative result is a bad thing.
To the exact contrary, science is about falsifying hypotheses.
Hope that helps!
TLDR negative results arent bad but everyone thinks they are -
Robin Carhart-Harris reposted
Amit Etkin
@AmitEtkin
Important new study
JAMA Psychiatry
@JAMAPsych
Functional unblinding and expectation may confound efficacy signals in #psilocybin trials for #depression, making it difficult to isolate therapeutic effects of psychedelic experiences from placebo and expectancy responses.
jamanetwork.com/journals/jamapsychiatry/fullarticle/10.10… -
Robin Carhart-Harris
@RCarhartHarris
Very silly headline to run based on a comparative analysis of apples vs oranges.
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Does it stack the deck in favor of the standard antidepressants to pull data from placebo-controlled trials for one condition (the psychedelic) and compare it with single condition data for the standard antidepressants? Also...
Balázs Szigeti
@psybalazs
🚨MAJOR NEW PAPER 🚨 just out in @JAMAPsych : Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions (tinyurl.com/yu2rbtaf).
I am very proud of this one, was a lot of work for me - both co-first and last author! Eternal gratitude to co-first @QuantPsychiatry and twitterless Hannah Barnett!
The premise is that it is biased to compare open-label trials (=where patients know what treatment they are getting) to blind trials (=where patients do NOT know what they are getting). Open-label trials would gain an unfair advantage by higher placebo response. Even formally blinded psychedelic trials are practically open-label as its obvious to distinguish placebo from 25mg of #psilocybin. In contrast, traditional antidepressants (SSRIs/SNRIs) trials are are close to be truly blind (Lin 2022). Given the bias of open-label vs. blinded comparison, we compared the efficacy of psychedelic-therapy (which is practically always open-label) vs. open-label antidepressants for the treatment of major depression.
We tested 3 prior hypothesis:
- There will be a significant difference between psychedelic-therapy vs. open-label antidepressants, favoring psychedelic-therapy.
- There will be a significant difference between blinded and open-label antidepressants trials, favoring open-label.
- There will NOT be a significant difference between blinded and open-label psychedelic-therapy, as practically they are always open-label.
In contrast with our prior hypothesis, we did not find psychedelic-therapy to be more effective than open-label antidepressants (H1). Not only was the difference not clinically meaningful, but practically there was no difference at all. This finding means that antidepressants administered knowingly to patients, which is the case in real-life medical practice, is as effective as psychedelic-therapy. This result was robust across variations in study selection, including when we removed psychedelic-therapy trials on treatment-resistant depression.
We also assessed the impact of blinding in both psychedelic-therapy and antidepressants trials. We found that for antidepressants (H2), but not for psychedelic-therapy (H3), open label is associated with better outcomes than blinded treatment. However, even in the case of antidepressants, the difference was practically small (~1.3 HAMD units).
How come hypothesis 1 failed, i.e. that psychedelic-therapy is no ore effective than open-label antidepressants, given that antidepressants trials are famous for small drug-placebo difference (~2.4 HAMD units), while psychedelic-therapy trials reported large effects (~7.3)? The key factor is that in psychedelic trials the placebo response is about 50% relative to antidepressants, ~ 4 vs 8 HAMD units (Hsu 2024, Hieronymus 2025). This suppressed placebo response leads to an inflated between-arm difference, as the treatment arm is measured against a lower floor.
The suppressed placebo response in psychedelic-therapy trials is likely attributable to the ‘know-cebo’ effect, i.e. the disappointment when patients realize they are in the control group. In psychedelic-therapy trials, this placebo suppression accounts for 4.0 / 7.3 ~ 55% of the specific treatment effect. In other words, ~55% of psychedelic-therapy’s effect is not explained by patient improvement after the treatment, but rather by the lack of improvement in the placebo group.
In summary, we found that for the treatment of depression, psychedelic-therapy is no more effective than open-label SSRIs/SNRIs. Our results for psychedelics are twofold: psychedelic-therapy demonstrated a robust and large therapeutic effects (~12 HAMD units), which justifies optimism. On the other hand, psychedelic-therapy’s lack of superiority compared to open-label SSRIs/SNRIs highlights the influence of blinding integrity and argues against overly optimistic narrative's about psychedelic-therapy's potential.
Robin Carhart-Harris
@RCarhartHarris
can we assume that ineffective blind activates a expectancy causation? I think we can for standard antidepressants (as evidence supports this) but not psychedelics (as evidence does not support this).
-
Robin Carhart-Harris
@RCarhartHarris
Magic vs psychology is a modern parse. It is of ego consciousness, not primary consciousness.
-
Robin Carhart-Harris reposted
Paul Brown
@0xQuasark
A 2021 study found that people who had taken psychedelics reported a 𝗽𝗲𝗿𝗺𝗮𝗻𝗲𝗻𝘁 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 in their connection to nature.
Not just during the experience.
𝗬𝗲𝗮𝗿𝘀 𝗮𝗳𝘁𝗲𝗿𝘄𝗮𝗿𝗱.
This effect was stronger than any other measured correlate of well-being.
Stronger than:
meditation,
therapy, or
exercise.
The word researchers used was:
"𝘯𝘢𝘵𝘶𝘳𝘦 𝘳𝘦𝘭𝘢𝘵𝘦𝘥𝘯𝘦𝘴𝘴."
Basically, the plants want you to come back. -
Robin Carhart-Harris reposted
Agustin Ibañez
@AgustinMIbanez
Music helps to understand the mind and the brain. Throughout the history of science, metaphors have shaped how we understand complex phenomena. The brain-as-computer metaphor has guided decades of theories and research. We propose music as a scientific metaphor for understanding the mind and brain via triplicate interfaces (listener, performer, composer) and a compound set of predictions. Multiple domains of music can be mapped onto different neural, cognitive and intersubjective processes such as network coordination, prediction, emotion and meaning. Neurocognition is not static but a dynamic, embodied, and time-sensitive system, much like a self-organized orchestra in which multiple processes interact simultaneously. Drawing on synergetics, predictive processing, and embodied cognition, we outline musical principles illuminating cognitive and action integration across time, offering new conceptual frameworks and testable predictions for future research. I enjoyed writing this piece with these stellar authors: @Kaiameye, @acolverson1, Christopher Bailey, @brucemillerucsf, @dafneduron90, Nicholas Johnson, Olga Castaner, @PierLuigiSacco, Eoin Cotter and Lucia Melloni. Science, like music, advances through new ways of listening to complex systems: doi.org/10.1016/j.neubiorev.2026.106643
-
Robin Carhart-Harris
@RCarhartHarris
"It's not magic, it's psychology."
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Sign up for my next newsletter, coming very soon! Join thousands of others receiving this update on all things "Carhart-Harris Lab". carhartharrislab.com
-
Robin Carhart-Harris reposted
Matthew W. Johnson
@Drug_Researcher
Just published: our RCT shows psilocybin (magic mushrooms) dramatically beats nicotine patch for quitting smoking using the same psychotherapy! A single psilocybin session showed 6x greater odds of staying quit. Biologically verified. In @JAMANetworkOpen Thread 🧵 #psychedelics #quitsmoking
-
Robin Carhart-Harris
@RCarhartHarris
Off all the constructs/phenomena that predict therapeutic response with psychedelic therapy, the best is emotional breakthrough (EB). It's not "oceanic boundlessness", it's not "mystical-type experiences," it's EB. Expect more on this soon...
Robin Carhart-Harris
@RCarhartHarris
*Of
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
Exciting & important new study from my lab. Have you ever wondered how strong that alleged connection is between psychedelic use and
#schizophrenia? This project aims to point the telescope there & give it a focused look. Please share widely. @AlexaM_Molinaro -
Robin Carhart-Harris reposted
Bryan Johnson
@bryan_johnson
My next longevity experiment: 5-MeO-DMT.
-
Robin Carhart-Harris
@RCarhartHarris
Exciting & important new study from my lab. Have you ever wondered how strong that alleged connection is between psychedelic use and
#schizophrenia? This project aims to point the telescope there & give it a focused look. Please share widely. @AlexaM_Molinaro -
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
This project aims to compliment the epidemiology work that has already been done. It will dive into those cases ("black swans" perhaps) where psychedelic use does seem to have played a causal role. We need to better understand these cases. The project is less about prevalence..
Robin Carhart-Harris
@RCarhartHarris
than causation and how compelling that direct causation is. Please help us give the project the best chance of success. Success = teaching us all something new (and perhaps unexpected) about this topic.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris reposted
Michael Pollan
@michaelpollan
(1) Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein themicrodose.substack.com/p/will-the-fda-ever-fast-track-…
-
Robin Carhart-Harris
@RCarhartHarris
Pleased to be included on this: pubmed.ncbi.nlm.nih.gov/41793582/ big up @NTFabiano for driving!
-
Robin Carhart-Harris
@RCarhartHarris
Dear Science Twitter, What software package(s) do you use to make cool science figures?
-
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
I'm not necessarily sure I like the term "illusion." "Vision(s)" is better.
-
Robin Carhart-Harris
@RCarhartHarris
Our all purpose study for capturing real-world psychedelic use data. We're beginning with a brief and easy version. Ideal for retreats+++. ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
Robin Carhart-Harris
@RCarhartHarris
Planning a trip? Check our short-and-sweet survey: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris reposted
Robert Y. Chen
@therealRYC
📋 Study Design
To find out, researchers compared classic psychedelics (LSD, psilocin, DOI) with nHAs.
It's important to understand: 5-HT2ARs are part of a class of receptors called G-protein coupled receptors.
You can think of it as a switchboard operator.
When a ligand binds, certain ligands will push the operator to route a call (i.e. activate a signaling pathway) one direction vs another.
They do this via various G-proteins or internal signaling molecules downstream, that are denoted with small subscripts (i.e. Gq - calcium; Gi - the decelerant; Arrestin - the brakes).
With that in mind, here's an overview of what the researchers did:
» Mapped downstream signaling (Gq vs Gi vs β-arrestin) in vitro
» Used mouse models: Head-twitch response (HTR) for hallucinations, forced swim test (FST) for depression
» Solved 5 high-res cryo-EM structures (resolutions of 2.62–3.27 Å) to map receptor binding
This is a gross oversimplification the immense work the researchers did.
But the key insight is looking at how different 5-HT2A binders differentially activated these various signaling pathways - not all "binding" is the same! -
Robin Carhart-Harris
@RCarhartHarris
Baseline Mood and “Relational Triad” Predict Acute Qualities of Psychedelic Experience www.mdpi.com/3739478 #mdpibehavsci via @Behavsci_MDPI
Robin Carhart-Harris
@RCarhartHarris
Big up Josh and Lisa for driving this, and Hannes for helping them!
-
Robin Carhart-Harris
@RCarhartHarris
Turns out only less than 40% of US public want to see psilocybin remain more or less entirely illegal.
Robin Carhart-Harris
@RCarhartHarris
When you add everything other than “illegal in every context” psilocybin sums to about 60% public approval for legal access.
Psychedelic Alpha
@Psyched_Alpha
RAND Survey: Americans Divided on Psilocybin, LSD, MDMA Legalisation
Read more in our latest Bulletin: psychedelicalpha.com/news/pα-psychedelic-bulletin-220-new… -
Robin Carhart-Harris
@RCarhartHarris
When you add everything other than “illegal in every context” psilocybin sums to about 60% public approval for legal access.
Psychedelic Alpha
@Psyched_Alpha
RAND Survey: Americans Divided on Psilocybin, LSD, MDMA Legalisation
Read more in our latest Bulletin: psychedelicalpha.com/news/pα-psychedelic-bulletin-220-new…
Robin Carhart-Harris
@RCarhartHarris
In fact, the numbers don’t entirely add to 100%, which is weird.
Robin Carhart-Harris
@RCarhartHarris
They’re quite far off 100. Can anyone make sense of that?
-
Robin Carhart-Harris reposted
Michael Pollan
@michaelpollan
How Michael Pollan Expanded His Consciousness | The New Yorker www.newyorker.com/books/book-currents/how-michael-pollan-…
-
Robin Carhart-Harris
@RCarhartHarris
So nice to run into this lovely chap at the train station in NYC. He’s book touring and I’m speaking at a dinner. Both in Boston.
-
Robin Carhart-Harris
@RCarhartHarris
Interesting. Still lots of educational work to do to better inform the public...
Psychedelic Alpha
@Psyched_Alpha
RAND Survey: Americans Divided on Psilocybin, LSD, MDMA Legalisation
Read more in our latest Bulletin: psychedelicalpha.com/news/pα-psychedelic-bulletin-220-new… -
Robin Carhart-Harris
@RCarhartHarris
AFCB, more than just a football club 🍒 ❤️
AFC Bournemouth 🍒
@afcbournemouth
"I had 48 shocks over 14 hours. I wanted to give up, but I am here."
February is National Heart Month. @DRBrooks15 went and met up with long-time supporter Dylan to hear his story. ♥️This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
I enjoyed listening to this. Science, deep ecology, spirituality bridge with each other. Complementary convergence. Sweet spot for wellness.
Martin Picard
@MitoPsychoBio
Our potential future US surgeon general.
Her focus on healing is spot on. Bringing Americans and great institutions together is an important step towards progress. -
Robin Carhart-Harris
@RCarhartHarris
Dementia is also just a society living longer… with lots of old brains… But sure, the point is we want to treat it better.
Martin Picard
@MitoPsychoBio
Our potential future US surgeon general.
Her focus on healing is spot on. Bringing Americans and great institutions together is an important step towards progress. -
Robin Carhart-Harris
@RCarhartHarris
Do you move from Maya to super Maya under DMT but push into Brahman under 5-MeO-DMT?
-
Robin Carhart-Harris
@RCarhartHarris
Yay! Really glad you discovered this work, Nirosha 😊 Freud wasn’t all bad after all! Turns out he was on to seem things 😊
Nirosha J. Murugan
@niroshajmurugan
Recently, I have been revisiting fundamental concepts across disciplines... like ego & energy. It has been eye-opening to reimagine concepts of “the self” within an energy dynamics framework.
Freudian concepts are often dismissed as unfalsifiable metaphors. Interestingly, Freud described the ego (“das Ich” or “the I”) as the result of a transformation of the unconscious’ free energy (creativity, instincts, aggression, dreams) into “bound energy”....organized, directed & controlled.
@RCarhartHarris & Karl Friston published a great piece, grounding the ego in the neurobiology of the default-mode network, which they argue works to suppress prediction errors, minimizing free energy.
Full read here: academic.oup.com/brain/article/133/4/1265/307446 -
Robin Carhart-Harris
@RCarhartHarris
Editor, author, agent, publishing house, talk show host.
-
Robin Carhart-Harris
@RCarhartHarris
This is fascinating and v nicely written. But these are human flaws, not those of “animals.” markmanson.net/ken-wilber @Markmanson
Robin Carhart-Harris
@RCarhartHarris
They’re flaws of ego consciousness, the quality of consciousness we’re inhabiting right now and most of the time.
-
Robin Carhart-Harris
@RCarhartHarris
So nice to hang with Matthew Reid, @ExistWell & @FredBarrettPhD at the legendary @JHPsychedelics today! Excited to dive into @ExistWell’s fab looking book.
-
Robin Carhart-Harris reposted
Johns Hopkins Psychedelic Research Center
@JHPsychedelics
A new review in Psychiatric Times synthesizes adverse event data for psilocybin, MDMA, ketamine, and ibogaine, highlighting that risk profiles differ meaningfully across compounds and that current reporting practices remain inconsistent. Clearer differentiation at the compound level will be essential as psychedelic research and clinical access continue to expand.
www.psychiatrictimes.com/view/adverse-events-and-psychede… -
Robin Carhart-Harris
@RCarhartHarris
Is this methylone?
Joshua Rosenblat, MD, MSc, FRCPC
@JD_Rosenblat
This looks incredibly promising for PTSD with a non-hallucinogenic psychedelic!
Efficacy and Safety of the Neuroplastogen TSND-201 for the Treatment of PTSD:
A Randomized Clinical Trial
@JAMAPsych
jamanetwork.com/journals/jamapsychiatry/fullarticle/28448…
Robin Carhart-Harris
@RCarhartHarris
An entactogen, like MDMA
-
Robin Carhart-Harris reposted
The Economist
@TheEconomist
For five years biotech startups have been betting that psychedelic substances could be turned into real medicines. One of them may have hit the jackpot econ.st/4rqmv1w
Photo: Getty Images -
Robin Carhart-Harris
@RCarhartHarris
Fantastic resource from @Psyched_Alpha
Psychedelic Alpha
@Psyched_Alpha
🎯 Q1 2026 BULLSEYE CHARTS: The Psychedelic Drug Development Pipeline
Today, we publish the latest edition of our Psychedelic Drug Development Bullseye Charts — a comprehensive overview of the psychedelic pipeline.
High-res: psychedelicalpha.com/news/q1-2026-psychedelic-drug-develo… -
Robin Carhart-Harris
@RCarhartHarris
This is a nice tool. Seems I've co-authored with 618 people within the last 4 years. Proud of that. #goteamscience! db.systemsbiology.net/gestalt/cgi-pub/NSF_COA.pl
-
Robin Carhart-Harris
@RCarhartHarris
Yup, a feature of ego consciousness.
Robin Carhart-Harris
@RCarhartHarris
And its negentropic imperative.
-
Robin Carhart-Harris
@RCarhartHarris
Grandpa Lynch. Rest well. A special one.
Jay Anderson
@TheProjectUnity
Filmmaker David Lynch's Diagram for Transcendental Consciousness is one of the greatest, easiest to understand explanations for how our reality is made of MIND first, MATTER second.
I promise this is genuinely worth your time.
It's fantastic.This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Looks interesting: www.nature.com/articles/s41386-026-02356-8
-
Robin Carhart-Harris
@RCarhartHarris
I read this recently: pubmed.ncbi.nlm.nih.gov/41444454/ It says 2A blocker studies often "over-dose the blocker" and thus lose specificity to 2A. Could this apply here? pubmed.ncbi.nlm.nih.gov/33850049/
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
E.g., α1-Adrenergic receptors block at that dose? Would sedate the animal, no?
-
Robin Carhart-Harris
@RCarhartHarris
This was the first demonstration of increased between network coupling (aka increased 'global network functional integration') under psychedelics: pubmed.ncbi.nlm.nih.gov/24904346/ @LeorRoseman
Robin Carhart-Harris
@RCarhartHarris
Note: the psychedelic did it but not the entactogen.
-
Robin Carhart-Harris
@RCarhartHarris
Ran 2 polls now. Most people say ibogaine is incomparable but if forced to liken it to another, it would be a classic psychedelic. Makes me suspect it does stim 2A or produces (glutamatergic) entropic effect via other pharmacology (like ketamine).
Robin Carhart-Harris
@RCarhartHarris
Based on personal experience, if you had to compare ibogaine or iboga to another drug/medicine/substance, what would it be?
Robin Carhart-Harris
@RCarhartHarris
What’s the best ref for its pharmacology?
-
Robin Carhart-Harris
@RCarhartHarris
Best articulation of hard problem I’ve ever heard. He’s right, of course. I discuss whether consciousness is one of the (many) exceptions to linear causation in the second chapter of my forthcoming book. Sign up for news on pre order here: carhartharrislab.com
vitrupo
@vitrupo
David Chalmers in 1998:
Consciousness is the one thing we know most directly. Yet science has explained stars and subatomic particles more successfully than experience itself.
“How does the water of the brain turn into the wine of consciousness?”
Three decades later, we still don’t know.This media couldn't be displayed. See it on the original post.
Robin Carhart-Harris
@RCarhartHarris
These exceptions operate as loops, whether with positive or negative feedback. Anxiety-heart rate, arousal-sweating, context-drug response, causal loops are ubiquitous in living systems. And subjective experience does have fundamental ontology, but
Robin Carhart-Harris
@RCarhartHarris
It’s extremism to say it’s the only (real) stuff of reality.
-
Robin Carhart-Harris
@RCarhartHarris
Is a "math makes it true" axiom problematic? Especially if it's a "I leave it up to the math experts to tell me it's true" axiom? I thought math was abstraction, idealization, not territory?
👽 (Ruby) 👽
@ObserveByProxy7
Donald Hoffman and co are on the brink of releasing PROOF that consciousness is fundamental and NOT produced by the brain. BREAKTHROUGH: How consciousness creates the simulation;
This media couldn't be displayed. See it on the original post.
Robin Carhart-Harris
@RCarhartHarris
Or in other words, how does math prove "hard idealism"?— seems almost a contradiction of itself...
-
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
more like it change in future. Mainstream (lack of) support for human neuro in psychedelic space has been woefully for too long. Has created rodent work with great pharma' but poor translational validity vs human work with weaker pharma' but direct/near-direct
-
Robin Carhart-Harris
@RCarhartHarris
Buzzy times: www.theguardian.com/science/2026/feb/16/psychedelic-drug-…
-
Robin Carhart-Harris
@RCarhartHarris
There's some wisdom here, perhaps. Absolute outcomes like response and remission may well be better post-approval. On this front, it's almost as if Compass stacked the deck against efficacy so as to "play the game" well. That's a clear contrast vs the Lycos story. It's a good point to end on.
Robin Carhart-Harris
@RCarhartHarris
Would be a curious break with conventional principles if this tx "gets better" post approval, but this isn't a conventional medicine...
-
Robin Carhart-Harris
@RCarhartHarris
Same point here. I think this is the main takeaway. To say it simply: on face value, Compass are still on track for approval, having played the game well.
-
Robin Carhart-Harris
@RCarhartHarris
Are "closed-eye visions" and "visual hallucinations" equivalent?— I've come to wonder and ask. Psychedelics induce the former and they're part of the tx action, tied up with phenomena like emotional breakthrough and insight.
-
Robin Carhart-Harris
@RCarhartHarris
This is reassuring. Key data. psychedelicalpha.com/news/breaking-second-positive-phase-…
-
Robin Carhart-Harris
@RCarhartHarris
This tickled me. I had to read it twice. "Psychedelic retreat".
Robin Carhart-Harris
@RCarhartHarris
Maybe a case for a hyphen.
-
Robin Carhart-Harris
@RCarhartHarris
Odd switch in definition of response criteria here. We're so used to 50+% reduction from baseline = "response". 40% responders at 25+% seems quite underwhelming tbh. We found much better in the original TRD trial (60% remission, month 3):(www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(1…):
Robin Carhart-Harris
@RCarhartHarris
A 25+% drop is clinically meaningful, it's just inconsistent with the standard criteria for response...
-
Robin Carhart-Harris reposted
Josh Hardman
@Josh__Hardman
Following the webcast now.
Kabir Nath, CEO, says that “effectiveness can be determined almost immediately after a single treatment.”
Guy Goodwin, CMO, describes the Phase 3 program as “robust” and “creative”, adding that “it cuts no corners.”
Psychedelic Alpha
@Psyched_Alpha
Breaking: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
$CMPS two-dose trial (COMP006) met its primary endpoint, reporting a −3.8 mean difference on MADRS vs 1 mg at week 6.
Our deep dive, including discussion with management, is live: psychedelicalpha.com/news/breaking-second-positive-phase-… -
Robin Carhart-Harris
@RCarhartHarris
This is significant: www.nature.com/articles/s41591-025-04154-z
-
Robin Carhart-Harris reposted
Josh Hardman
@Josh__Hardman
Busy day tomorrow!
Psychedelic Alpha
@Psyched_Alpha
Tomorrow, Compass Pathways will share 6-week data from its second, larger Phase 3 study of its psilocybin candidate in treatment-resistant depression.
It will also share 26-week data from its first Phase 3.
Psychedelic Alpha has the full story tomorrow AM. -
Robin Carhart-Harris
@RCarhartHarris
Join me in raising money for Ripples Alliance! via @givebutter givebutter.com/xAUEym
-
Robin Carhart-Harris
@RCarhartHarris
Breaking news! Lionel Messi takes DMT!
Joe Rogan Podcast News
@joeroganhq
"What's the best piece of advice you've ever received from a DMT entity?"
Robin Carhart-Harris
@RCarhartHarris
Me to my son- “look at messi”, son- “that’s not messi”
-
Robin Carhart-Harris
@RCarhartHarris
Based on personal experience, if you had to compare ibogaine or iboga to another drug/medicine/substance, what would it be?
-
Robin Carhart-Harris
@RCarhartHarris
Lots of free prep and integration vids here. www.carhartharrislab.com/video-library
-
Robin Carhart-Harris
@RCarhartHarris
Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study doi.org/10.1556/2054.2026.00485
-
Robin Carhart-Harris
@RCarhartHarris
Meta-analysis of HPPD cases in clinical trials. I know about the naturalistic use studies but wondering about trials, specifically. Anything published on that?
-
Robin Carhart-Harris
@RCarhartHarris
Classical/mechanistic/technology/macroscopic/ego consciousness/maya/yang vs quantum/organic/spirituality/microscopic/the unconscious/brahman/atman/yin
Robin Carhart-Harris
@RCarhartHarris
Deterministic/concrete vs probabilistic/abstract
-
Robin Carhart-Harris reposted
Michael Pollan
@michaelpollan
‘I’m the psychedelic confessor’: the man who turned a generation on to hallucinogens returns with a head-spinning book about consciousness | Books | The Guardian www.theguardian.com/books/2026/feb/08/michael-pollan-psyc…
-
Robin Carhart-Harris
@RCarhartHarris
“Mystics understand the roots of Tao but not its branches.”
Robin Carhart-Harris
@RCarhartHarris
Classical/mechanistic/technology/macroscopic/ego consciousness/maya/yang vs quantum/organic/spirituality/microscopic/the unconscious/brahman/atman/yin
Robin Carhart-Harris
@RCarhartHarris
“Scientists understand its branches but not its roots.”
-
Robin Carhart-Harris reposted
Julie Holland, MD
@BellevueDoc
Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin
www.nature.com/articles/s41380-026-03447-0 -
Robin Carhart-Harris reposted
TruthtideTV
@TruthtideTV
Yet, there is still such a thing as "too much".
Just a reminder. -
Robin Carhart-Harris
@RCarhartHarris
Sign up for my next newsletter, coming this Sunday (hopefully)! Sign up happens here: carhartharrislab.com
-
Robin Carhart-Harris reposted
Joshua Siegel
@realJoshSiegel
I got to work with a psychedelic dream team on this! @RCarhartHarris, Conor Liston, Ginger Nicol, and Michael Bogenschutz
Very proud of what came out of it - - a rigorous, insightful, and authoritative review IMHO
Nature Medicine
@NatureMedicine
New Review: The science of #psychedelic medicine.
Joshua Siegel & colleagues integrate mechanistic knowledge with clinical evidence across neuropsychiatric indications — highlighting challenges, controversies, and opportunities.
@realJoshSiegel @RCarhartHarris @nyugrossman
www.nature.com/articles/s41591-025-04194-5 -
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
“Love is like gravity”
-
Robin Carhart-Harris reposted
Nature Medicine
@NatureMedicine
New Review: The science of #psychedelic medicine.
Joshua Siegel & colleagues integrate mechanistic knowledge with clinical evidence across neuropsychiatric indications — highlighting challenges, controversies, and opportunities.
@realJoshSiegel @RCarhartHarris @nyugrossman
www.nature.com/articles/s41591-025-04194-5 -
Robin Carhart-Harris
@RCarhartHarris
Have some very juicy papers coming for y'all in the next few months.. 😊
Robin Carhart-Harris
@RCarhartHarris
Weeks/months...
-
Robin Carhart-Harris reposted
Julie Holland, MD
@BellevueDoc
LSD Reconfigures Cortical Dynamics Through Faster Brain Rhythms and Increased Fractal Dimension
www.biorxiv.org/content/10.64898/2026.01.28.702361v1.full… -
Robin Carhart-Harris reposted
Christian Angermayer
@C_Angermayer
Today’s chatter about @COMPASSPathway's Comp360 drug being “snubbed” for a National Priority Voucher is making a mountain out of a molehill.
There is this persistent false assumption that approving psychedelics for medical use could be a political issue or decision. It is not - and it should never be.
Like any other novel therapeutic, psychedelic compounds must demonstrate efficacy and safety through rigorous, FDA-regulated clinical trials.
The good news: multiple late-stage programs are reaching maturity, and I believe the coming years will be a watershed moment for the field as data continue to meet the FDA’s gold-standard approval bar.
As the article notes itself, the National Priority Voucher is - at least in part - a political decision. I was - and remain - extremely skeptic to make psychedelics a “political thing”.
We have to acknowledge that these therapeutics come with a history and “baggage”. Not fair, but historical fact. This is why, since the founding of @ataibeckley, I have continuously pushed for us to go the extra mile.
Cutting corners, or even giving people the impression of doing that, would be of huge disservice to the entire field. This is why I have been vocally critical about how Lykos handled their imo justified rejection, for example.
Today’s headline is another try to make this a political story. Because the Trump administration can be a polarizing topic, it makes the narrative even more enticing for some.
But already within the article itself – which is much more balanced than the headline, but behind a paywall – one can read, correctly, that the voucher in any case wouldn’t have changed anything more or less, and that “the FDA is allowing … to submit data on a rolling basis, which should get Compass a decision potentially late this year or early next year, much earlier than previously expected.”
I fully agree with an analyst who is quoted that “Compass’ exclusion from the voucher program might even be a blessing in disguise… Approving the first psychedelic medication through a controversial FDA pathway could raise questions about whether corners were cut as part of an expedited review, setting back the field.”
I want to say it again: #psychedelics have shown real, meaningful potential as therapeutics for mental‑health disorders. The rigorous FDA process will decide where they land, but nothing about this field requires shortcuts or political favors. The data - as they continue to emerge - will speak for themselves.
$ATAI $CMPS $GHRS $DFTX -
Robin Carhart-Harris
@RCarhartHarris
Please share.
Robin Carhart-Harris
@RCarhartHarris
Planning a trip? Check our short-and-sweet survey: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
Planning a trip? Check our short-and-sweet survey: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
Psychedelics Align Brain Activity with Context www.biorxiv.org/content/10.1101/2025.03.09.642197v1
-
Robin Carhart-Harris
@RCarhartHarris
Big up Jake and co! Blunted Psychedelic Drug Effects in Older Adults www.sciencedirect.com/science/article/pii/S1064748126000254
-
Robin Carhart-Harris
@RCarhartHarris
Psychedelic visions are fluid ever changing Maya
-
Robin Carhart-Harris
@RCarhartHarris
Nature is a sphynx, she often answers in paradoxes.
Robin Carhart-Harris
@RCarhartHarris
Sphinx
-
Robin Carhart-Harris
@RCarhartHarris
Imagine if people across the world started to dream for the first time and got so excited by it, wondering if the dream world is literally another world, another dimension you can visit and a mass hysteria ensued. It’s interesting people want so much to believe in the literal Other.
Graham Hancock
@Graham__Hancock
Who or what are the seemingly sentient entities that volunteers report encountering in DMTX (extended DMT) scientific trials? Thanks to my son Luke Hancock for this excellent interview with one of the volunteers, Batuhan Bintas, who gives us a first-hand glimpse into the mystery:
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Visiting legends—like Bill—at Hopkins, 14 years ago...
Robin Carhart-Harris
@RCarhartHarris
Barely a gray hair on my head!
-
Robin Carhart-Harris
@RCarhartHarris
I was enjoying this but then spotted a glaring issue: mdma lumped in with amphetamine and classed as a “stimulant” and then contrasted against psychedelics… Ok, it’s not a classic psychedelic but it’s not speed either! — Really?!? 🤷♂️
Robin Carhart-Harris
@RCarhartHarris
Skim read this and so far makes lots of sense. www.medrxiv.org/content/10.64898/2026.01.15.26344193v1.fu…
Robin Carhart-Harris
@RCarhartHarris
Quite impressed that all entropy metrics sensitive to psychedelics and most also specific (vs amphetamine) in the relevant (high level) cortical regions. Replicates work like this: www.nature.com/articles/s41586-024-07624-5
Robin Carhart-Harris
@RCarhartHarris
No doubt this Mis-classification of mdma will get picked up in review. Cue that star wars meme thing… “it will get picked up in review, right?…”
Robin Carhart-Harris
@RCarhartHarris
Better practice would be to separate amphetamine and mdma as two distinct psychoactive controls to compare the 2a agonist classic psychedelics against.
Robin Carhart-Harris
@RCarhartHarris
Apart from that, it’s a great idea and paper.
-
Robin Carhart-Harris
@RCarhartHarris
Pharmacology and phenomenology are important. Let’s be more precise with both.
BryanRoth
@zenbrainest
Hmmm…perhaps pharmacology is important?
Robin Carhart-Harris
@RCarhartHarris
Better practice would be to separate amphetamine and mdma as two distinct psychoactive controls to compare the 2a agonist classic psychedelics against.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Share the love, y'all! Music For Mushrooms (Full Film) | Award-Winning Documentary | 4K youtu.be/N3EvV2_XE_Y via @YouTube
-
Robin Carhart-Harris
@RCarhartHarris
🖐️ Miss! Miss! I’ve finished, Miss! 🖐️ - A remarkable read indeed!
Robin Carhart-Harris
@RCarhartHarris
Presages the entropic brain.
-
Robin Carhart-Harris
@RCarhartHarris
Skim read this and so far makes lots of sense. www.medrxiv.org/content/10.64898/2026.01.15.26344193v1.fu…
-
Robin Carhart-Harris
@RCarhartHarris
“The kingdom of God as a big family” - Very interesting…
-
Robin Carhart-Harris
@RCarhartHarris
Providence ~ inner healer
-
Robin Carhart-Harris
@RCarhartHarris
This
-
Robin Carhart-Harris
@RCarhartHarris
AGI/LLMs as the “eyes of the noosphere”?
Robin Carhart-Harris
@RCarhartHarris
“How could one think of the development of AGI in relation to Chardin’s omega point?”chatgpt.com/s/t_696f04dca50c8191ba8683434d1e78f8
-
Robin Carhart-Harris
@RCarhartHarris
Life (collective global consciousness in the noosphere) after death (entropy increase as per second law). The longer curve of evolution that is forever building/growing/developing..:
-
Robin Carhart-Harris
@RCarhartHarris
“How could one think of the development of AGI in relation to Chardin’s omega point?”chatgpt.com/s/t_696f04dca50c8191ba8683434d1e78f8
-
Robin Carhart-Harris
@RCarhartHarris
Lovely work, moving the needle on consciousness, criticality, entropy and the brain. Big up @marcoaqil and co!
Marco Aqil
@marcoaqil
Great start of the year with a fantastic collaboration published in the Journal of Neuroscience! (thread) www.jneurosci.org/content/46/2/e0344252025
-
Robin Carhart-Harris reposted
Marco Aqil
@marcoaqil
Great start of the year with a fantastic collaboration published in the Journal of Neuroscience! (thread) www.jneurosci.org/content/46/2/e0344252025
-
Robin Carhart-Harris reposted
Marco Aqil
@marcoaqil
Many thanks to all coauthors for this great collaboration, and special thanks to Mona Irrmischer, Klaus Linkenkaer-Hansen, @lisaxiaolu, Chris Timmermann, @RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Interesting stuff: pubmed.ncbi.nlm.nih.gov/41265656/
-
Robin Carhart-Harris
@RCarhartHarris
Check it!
-
Robin Carhart-Harris
@RCarhartHarris
Entropy is a thermometer of consciousness.
Robin Carhart-Harris
@RCarhartHarris
Obviously needs a few qualifiers but Wouldn’t have sounded as cute with them…
Robin Carhart-Harris
@RCarhartHarris
Anaesthetised state is cold, psychedelic state is hot.
-
Robin Carhart-Harris
@RCarhartHarris
Clever Neanderthals in England 400K yrs ago: Archaeologists Find Oldest Evidence of Fire-Making www.nytimes.com/2025/12/10/science/archaeology-humans-nea…
-
Robin Carhart-Harris
@RCarhartHarris
Has anyone read this? Thoughts? www.wouterjhanegraaff.net/newagereligion
-
Robin Carhart-Harris
@RCarhartHarris
Enjoyed this. Phenomenology made me think of ketamine. Are there a lot of NMDA receptors in the anterior precuneus?
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
This is a good read on the history and basics of neuroplasticity. A sticking point for me: many of the best known types of neuroplasticity produce the opposite of plasticity per se ie they produce canalization (ie phenotypic resistance to change). I plan to write/publish on this paradox this year.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Nice to see so much interest. Here’s the open access paper: pmc.ncbi.nlm.nih.gov/articles/PMC6400842/pdf/fncel-13-000…
Robin Carhart-Harris
@RCarhartHarris
This is a good read on the history and basics of neuroplasticity. A sticking point for me: many of the best known types of neuroplasticity produce the opposite of plasticity per se ie they produce canalization (ie phenotypic resistance to change). I plan to write/publish on this paradox this year.
-
Robin Carhart-Harris
@RCarhartHarris
Struggling to integrate a trip? Check this: A psychedelic therapist's guide to integration with Marc Aixalà youtu.be/1nUEQS21200 via @YouTube
-
Robin Carhart-Harris
@RCarhartHarris
Pierre asks “is life going anywhere?”; it’s interesting to ask, with psychedelics in mind, “is all of this experience going anywhere, does it have a direction?”
Robin Carhart-Harris
@RCarhartHarris
He thinks it is. I also think “all of this experience” is too… it’s arcing somewhere, not somewhere final, as such, but trending, slightly, in a particular direction…
Robin Carhart-Harris
@RCarhartHarris
Of course, it’s that. It’s the same thing - for life - as for experience.
-
Robin Carhart-Harris
@RCarhartHarris
I enjoyed this. K is clearly a very important and useful medicine when used right. @ProfDavidNutt
-
Robin Carhart-Harris
@RCarhartHarris
Excited to be reading this.
Robin Carhart-Harris
@RCarhartHarris
Makes intuitive sense.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Good to see but not sure it's helpful or accurate to lump in Ketamine as a psychedelic. osf.io/preprints/psyarxiv/5ybhk_v1 Also, brain image does not show more activity. It shows expanded visual cx communication. Pernickety points but fair & needed.
Psychedelic Alpha
@Psyched_Alpha
BBC News Clip: New Research Shows Benefits of Psychedelic Drugs
www.bbc.co.uk/iplayer/episode/l0057t33/new-research-shows…
Robin Carhart-Harris
@RCarhartHarris
And good to see Ian. Top chap.
-
Robin Carhart-Harris
@RCarhartHarris
Hope you liked it. If you missed it, Sign up now for next month’s: carhartharrislab.com
Robin Carhart-Harris
@RCarhartHarris
Sign up now to get this tomorrow!
Robin Carhart-Harris
@RCarhartHarris
Join thousands receiving my next newsletter. Hear my thoughts on 1) a 20 yr rereading of Grof’s realms of the human unconscious, 2) a preprint on psychedelics accelerating brain tumour growth, + 3) a reading from my forthcoming book- & more. Sign up here: carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
Good to see this inc. the recognition of the live and recruiting UCSF set and setting study design (www.carhartharrislab.com/studies): Psychological support can be distinguished from psychotherapy: Clarifi... www.sciencedirect.com/science/article/pii/S0163834325002506
Robin Carhart-Harris
@RCarhartHarris
To keep things simple, we define and control and enriched vs unenriched set and setting. We're also careful to select the right population to test the H1 sufficiently safely.
Robin Carhart-Harris
@RCarhartHarris
Different focus in testing role of psychotherapy (vs psychological support) specifically. My 2 cents sense is that it would be hard to see a large effect of psychotherapy vs psychological support in most populations.
-
Robin Carhart-Harris
@RCarhartHarris
Sign up now to get this tomorrow!
Robin Carhart-Harris
@RCarhartHarris
Join thousands receiving my next newsletter. Hear my thoughts on 1) a 20 yr rereading of Grof’s realms of the human unconscious, 2) a preprint on psychedelics accelerating brain tumour growth, + 3) a reading from my forthcoming book- & more. Sign up here: carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
Powerful ending. Not the first time I’ve heard such life-saving claims.
Robin Carhart-Harris
@RCarhartHarris
Good to see this (inc some brain images I made once upon a time). Pretty good article. I strongly suspect Compass will get fda approval this year and that will be the major milestone of this era. www.bbc.co.uk/news/articles/ckg936l88e7o
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
Hey Tim @tferriss, We have looked a few times and measures like cortical thickness and volumetric changes have yet to really come through. We have found some changes in white matter tracts though and are about to publish on this. Pre-print here: www.biorxiv.org/content/10.1101/2024.10.11.617955v1.full.pdf
-
Robin Carhart-Harris
@RCarhartHarris
Good to see this (inc some brain images I made once upon a time). Pretty good article. I strongly suspect Compass will get fda approval this year and that will be the major milestone of this era. www.bbc.co.uk/news/articles/ckg936l88e7o
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
The entropic brain today osf.io/preprints/psyarxiv/ubzq3_v1 via @OsfFramework
-
Post not available here, view on XPost not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Hey Tim @tferriss, We have looked a few times and measures like cortical thickness and volumetric changes have yet to really come through. We have found some changes in white matter tracts though and are about to publish on this. Pre-print here: www.biorxiv.org/content/10.1101/2024.10.11.617955v1.full.pdf
-
Robin Carhart-Harris
@RCarhartHarris
Nice from Pierre Teilhard de Chardin. This is starting to warm up as a read…
-
Robin Carhart-Harris
@RCarhartHarris
Who’s this person?
Alex Berenson
@AlexBerenson
Everybody who hates SSRIs and loves psychedelics knows psychedelics are basically absurdly souped-up SSRIs, right?
I mean, you all know that, right? You understand the mechanisms of action here, right?
Right? -
Robin Carhart-Harris
@RCarhartHarris
Reading this and finding it excellent. Great to see such psychological sophistication coming into psychedelic medicine. Timed just right. Without this, the field is precipital, with it- it is strong and truly poised to advance psychiatry and wellness.
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
“Precipitous” would have been a better word for what I meant. Like, risk it could all fall down.
-
Robin Carhart-Harris
@RCarhartHarris
Some nice stuff from Julian Huxley here in his 1958 intro to “the phenomenon of man”
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
Green = less Gray matter. Short story: It’s shrinkage all over and especially severe in schizophrenia!
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
People with mental illness have reliably less gray matter!
Robin Carhart-Harris
@RCarhartHarris
H1: GM atrophy: major driver of canalization.
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Green = less Gray matter. Short story: It’s shrinkage all over and especially severe in schizophrenia!
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Emergence of archetypal visions under DMT, psilocybin, LSD or ayahuasca: correlate with recovery of an inhibitory stencil in ventral visual stream?
Robin Carhart-Harris
@RCarhartHarris
I wonder if recordings of this nature ^ could be done in conscious humans?
-
Robin Carhart-Harris
@RCarhartHarris
I’m curious whether @drmichaellevin has considered modulation (temporary increases) of the entropy of dendritic fields under psychedelics as a potential regenerative mechanism in mental health+? osf.io/preprints/psyarxiv/ubzq3_v1
Robin Carhart-Harris
@RCarhartHarris
This is interesting. “To counteract ageing, it is therefore necessary to reactivate a developmental/regenerate goal.”
-
Robin Carhart-Harris
@RCarhartHarris
This is interesting. “To counteract ageing, it is therefore necessary to reactivate a developmental/regenerate goal.”
-
Robin Carhart-Harris
@RCarhartHarris
Join thousands receiving my next newsletter. Hear my thoughts on 1) a 20 yr rereading of Grof’s realms of the human unconscious, 2) a preprint on psychedelics accelerating brain tumour growth, + 3) a reading from my forthcoming book- & more. Sign up here: carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
Hadn’t realised until now that in this pivotal mental states paper, I used a “fork in river” (right) analogy that is consistent with a “watershed moment” metaphor (left). Will 2026 bring a watershed moment for psychedelic medicine? journals.sagepub.com/doi/pdf/10.1177/0269881120959637
-
Robin Carhart-Harris
@RCarhartHarris
This was a good read. Persistent Antidepressive rodent behavior after single dose psychedelic, persistent neural excitability yet no persistent synaptogenesis. Perhaps we’ve got the emphasis wrong when spotlighting key brain changes linked to psychedelic-therapy response.
Robin Carhart-Harris
@RCarhartHarris
Found it interesting that dendritic spines eliminate at faster rate (than saline control) after 2 weeks post dose. Previous work.
Robin Carhart-Harris
@RCarhartHarris
^ ketamine
Robin Carhart-Harris
@RCarhartHarris
Also funny how “plasticity” became shorthand for “neuroplasticity”
-
Robin Carhart-Harris
@RCarhartHarris
Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks: Cell www.cell.com/cell/fulltext/S0092-8674(25)01305-4
Robin Carhart-Harris
@RCarhartHarris
Finally got round to reading this. Found it quite difficult tbh. Such high impact rodent neuro: I’m often left impressed with the thoroughness of the methods but bamboozled by its translational meaning.
Robin Carhart-Harris
@RCarhartHarris
*baffled as to. Is the point that it weakens canalisation?
-
Robin Carhart-Harris
@RCarhartHarris
I love that album by Mescaleros! Ends on a poignant note. Nice to think of Joe this time, reminded it’s the anniversary. Still remember the day. Saluted him with pint in a pub in old town Poole, Dorset. @hubermanlab
Andrew D. Huberman, Ph.D.
@hubermanlab
Joe Strummer gone 23 years now, today. (Died 50 yo). 101ers, The CLASH, ran the Paris Marathon as a smoker (his girlfriend a French model ran it too), Mescaleros (!), songs w/JCash. His most important work was his reminder that The Future is Unwritten. This is a special one:
This media couldn't be displayed. See it on the original post.
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
Measuring quality of life in mental health: Are we asking the right qu... www.sciencedirect.com/science/article/pii/S0277953614005437
-
Robin Carhart-Harris reposted
Psychedelic Alpha
@Psyched_Alpha
Pα+ Psychedelic Bulletin #216:
- Australia’s Psychedelics-for-Veterans Funding
- New Mexico Targets 2026 Medical Psilocybin Launch
- Otsuka’s “Novel Serotonergic Agonists”
- Psilocybin Accelerates Brain Tumour Growth in Mice
- TX $50M Ibogaine Study
psychedelicalpha.com/news/pα-psychedelic-bulletin-216-aus… -
Robin Carhart-Harris
@RCarhartHarris
Selective caution for those with glioma that SSRIs, psychedelics and other serotonergic medications might accelerate growth in humans.
Josh Hardman
@Josh__Hardman
🐁 Very concerning finding: Psilocybin promotes brain tumour growth
Authors caution against use of 5-HT2A agonists like psilocybin in patients with glioma, "given the profound and sustained tumor growth-promoting effects observed."
Extends to other serotonergic drugs like LSD.
Robin Carhart-Harris
@RCarhartHarris
I spoke with the first and senior author of this work a couple of weeks ago and knew this was coming. I have some thoughts to share and will share them in my next newsletter. carhartharrislab.com
Robin Carhart-Harris
@RCarhartHarris
One thought I’ll share now is that I can see how there’s scope here for people to inflate and dismiss the work and its findings. I hope a measured interpretation comes through.
Robin Carhart-Harris
@RCarhartHarris
*glioma/tumor growth.
-
Robin Carhart-Harris reposted
Andrew D. Huberman, Ph.D.
@hubermanlab
The new Huberman Lab episode is out: Improve Energy & Longevity by Optimizing Mitochondria | Dr. Martin Picard (@MitoPsychoBio)
0:00 Martin Picard
3:50 What is Energy?, Energy Flow & Transformation
7:53 Energy, Vitality, Emotions, Sensory Perception
14:18 Sponsors: Helix Sleep & Lingo
17:19 “Mito-Centric” View of World, Mitochondrial Energy & Information Patterns
25:26 Organelles, Mitochondria & Energy Transformation; Maternal Genes
31:12 Mitotypes & Differentiation, Mitochondria as “Social Organisms”
36:52 Food & Dysfunctional Energy Transformation
40:02 Lifestyle Choices & Interests, Physiological Growth
46:39 Pregnancy, Amenorrhea; Illness & Tiredness
51:07 Sponsor: AG1
52:29 Energy Transformation & Distribution; Body’s Wisdom, Feeling Sick
56:27 Tool: Feel Your Energy; Breath & Energy
1:02:31 Flow of Energy; Trade-Offs, Life Purpose & Enjoyment
1:10:15 Biology, Meaningful Experiences & Energy Flow
1:16:27 Sponsor: Function
18:15 Inflammation, Energetic Flow
1:20:43 Child Prodigies, Species Lifespan & Mitochondrial Metabolism; Aging
1:28:56 Lifestyle & Aging: Exercise, Fasting; Inflammation, Sleep, Stimulants
1:37:06 Energetic Stress Signals, GDF-15, Cancer, Heart Failure
1:42:18 Genes, Lifestyle & Aging
1:47:54 Gray Hair Reversal, Stress; Inflammation & Aging
1:57:37 Energy Recovery, Sleep & Mitochondrial Function, Stress, Meditation
2:05:16 Tools: Yoga Nidra, NSDR; Pre-Sleep Relaxation, Energy & Restorative Sleep
2:10:58 Diet & Individualization, Clinical Trials; Mitochondria & Nutrition, Keto
2:20:14 Alcohol & Energy Budget; Stress
2:25:02 Exercise, Increase Mitochondria, Overtraining; Resistance & Growth
2:33:06 Sponsor: Waking Up
2:34:41 Supplements & Mitochondria Health, Deficiencies, SS31, Methylene Blue
2:41:31 Energy Flow & Experiences, Balance
2:49:13 Transform Through Resistance, Energetic Awareness, Connection
2:56:05 Food Overconsumption & Mitochondria Disruption; Tissues & Mitochondria
3:01:02 Mitochondrial Health Test; Tool: Ways to Increase Energy; Meditation
3:06:10 Peptides; Fertility Supplements, Urolithin A; Electromagnetic Fields
3:12:16 Acknowledgements
3:14:15 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter
Includes paid partnerships.This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Quiet the mind, tend the heart. podcasts.apple.com/us/podcast/heart-wisdom-with-jack-korn…
-
Robin Carhart-Harris
@RCarhartHarris
The entropic brain today osf.io/preprints/psyarxiv/ubzq3_v1 via @OsfFramework
-
Robin Carhart-Harris
@RCarhartHarris
2026 will see a further uptick in psychedelic drug development evidence with the breakthrough event either Q4 2026 or early 2027.
-
Robin Carhart-Harris
@RCarhartHarris
Revisiting realms of the human unconscious after >20 years (mad!) and it’s quite a different experience this time around. Will say some words on this for my next newsletter.
Robin Carhart-Harris
@RCarhartHarris
But one thought now is: bloody hell! Talk about the blood and guts of human experience! It’s almost like shock art!
-
Robin Carhart-Harris
@RCarhartHarris
Not sure what to conclude from this... Is there a there there? No-one really knows... But over 75% of folk sense there might be...
Robin Carhart-Harris
@RCarhartHarris
Poll below.
Robin Carhart-Harris
@RCarhartHarris
My mind also goes to Michael Levin's work that memory can be encoded in novel (non-synaptic) ways within an organism's physiology.
-
Robin Carhart-Harris reposted
Robin Carhart-Harris
@RCarhartHarris
A new pre-print from my lab + colleagues. Defining ‘psychedelic’ osf.io/preprints/psyarxiv/5ybhk_v1 via @OsfFramework
-
Robin Carhart-Harris reposted
Massimo
@Rainmaker1973
Mushrooms evolved into psilocybin twice.
A fascinating new study has revealed that psilocybin—the psychedelic compound in magic mushrooms—arose not once, but twice, through entirely independent evolutionary events in distant corners of the fungal kingdom.
In the familiar Psilocybe species, psilocybin is assembled via a well-characterized four-enzyme pathway. Yet when scientists examined certain small, drab fiber cap mushrooms (from genera like Inocybe and allies), they discovered a completely unrelated biochemical assembly line: different genes, different enzymes, different intermediate steps—yet the end product is chemically identical.
This is a remarkable case of convergent evolution: two lineages, with no shared ancestry for this trait, each invented their own molecular machinery to manufacture the same powerful molecule.
Why fungi bother making psilocybin at all is still unclear. Some hypothesize it serves as a defense chemical (the blue bruising reaction in damaged Psilocybe tissue hints at this), while others propose roles in inter-species signaling or entirely unknown ecological functions. Whatever the benefit, it was evidently strong enough for natural selection to favor it twice, in very different habitats.
The finding also carries immediate practical value. With psilocybin advancing in clinical trials for treatment-resistant depression and other conditions, having two distinct biosynthetic pathways gives researchers multiple genetic toolkits for engineering microbes or yeast to produce the compound in bioreactors—potentially making therapeutic-grade psilocybin far cheaper and more scalable.
In the end, nature quietly solved the same chemical puzzle twice, deep in the soil, millions of years apart—and only now are we stumbling across its elegant, redundant handiwork.
[“Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.” Angewandte Chemie International Edition, 2025] -
Robin Carhart-Harris
@RCarhartHarris
Poll: Best answered if you’ve read Grof but do you feel our adult psychological structure is influenced by the nature of our experiences in utero and during birth (as the baby)?
Robin Carhart-Harris
@RCarhartHarris
Poll below.
Robin Carhart-Harris
@RCarhartHarris
Please share any links to relevant evidence that you’re aware of.
-
Robin Carhart-Harris
@RCarhartHarris
New newsletter this Sunday. Sign up here— or tell a friend. carhartharrislab.com
Robin Carhart-Harris
@RCarhartHarris
Hope you liked it ☺️👍
-
Robin Carhart-Harris reposted
Michael Pollan
@michaelpollan
Advance review of A World Appears from @RCarhartHarris 🍄 Robin’s Brainwaves: the many ways a world appears mailchi.mp/d311ac935a1c/welcome-to-the-first-edition-of-r…
-
Robin Carhart-Harris
@RCarhartHarris
Planning to trip soon? Check this: ucsf.co1.qualtrics.com/jfe/form/SV_2rGNuzYxXyWawE6
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
I’ve written a nearly 10K word update on the entropic brain. Should I pre-print it?
-
Robin Carhart-Harris
@RCarhartHarris
Spatial computing offers a model for why archetypal visions come and go, switching under psychedelic
podcasts.apple.com/us/podcast/brain-inspired/id1428880766…
Robin Carhart-Harris
@RCarhartHarris
“Your brain is like a gazzilion neurons all smooshed together, all interacting” - love that part.
Robin Carhart-Harris
@RCarhartHarris
I also like “think of your brain like a giant orchestra, the melody plays on but the individual players come and go” - it’s like a metaphor for the noosphere too.
-
Robin Carhart-Harris reposted
Genevieve Jurvetson
@gjurvetson
Stanford just published a beautiful obituary for our dear friend, Dr. Nolan Williams. His pioneering work with neuromodulation and plant medicines transformed countless lives, ushering in a new era of psychiatry focused on true healing.
Tomorrow, Nolan's TED talk will go live. It brings me some peace knowing his mission continues, and that more people will learn from his brilliance, bravery, and compassion. I miss him so much.
Please keep his family in your hearts.
📸 by Keith Westra
med.stanford.edu/news/all-news/2025/12/nolan-williams-obi… -
Robin Carhart-Harris
@RCarhartHarris
A new pre-print from my lab + colleagues. Defining ‘psychedelic’ osf.io/preprints/psyarxiv/5ybhk_v1 via @OsfFramework
-
Robin Carhart-Harris
@RCarhartHarris
Flashback to 2016: The paradoxical psychological effects of lysergic acid diethylamide (LSD) | Psychological Medicine | Cambridge Core - www.cambridge.org/core/journals/psychological-medicine/ar…
-
Robin Carhart-Harris
@RCarhartHarris
Flashback to 2013! Psychiatry’s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders - RL Carhart-Harris, S Brugger, DJ Nutt, JM Stone, 2013 journals.sagepub.com/doi/10.1177/0269881113494107?url_ver…
-
Robin Carhart-Harris
@RCarhartHarris
Thoughts on the GLP1 agonist x psychedelic issue? psychedelicstoday.com/2025/08/05/glp-1-drugs-psilocybin-m…
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
"The prison house begins to close upon the growing boy". This is very cool! --- Precision functional mapping reveals less inter-individual variability in the child vs. adult human brain www.biorxiv.org/content/10.1101/2025.07.21.665760v1
-
Robin Carhart-Harris
@RCarhartHarris
Great final page. I really enjoyed this book. Gave me a lot. I suspect it will stay with me. @TheKenWilber
-
Robin Carhart-Harris
@RCarhartHarris
Funny that he felt he had to write this book (published In 2000) without mentioning the psychedelic elephant in the room…
-
Robin Carhart-Harris
@RCarhartHarris
There’s a there there…
Paul Brown
@0xQuasark
The one thing Bryan Johnson hates doing on shrooms:
-
Robin Carhart-Harris
@RCarhartHarris
Published in 2000, it’s hard not to see these thoughts as impressively prescient… @TheKenWilber
-
Robin Carhart-Harris
@RCarhartHarris
Most of way through this already. I wondered whether it might offer an answer to the gaps/shortcomings in the “new age movement”. So far, it partially does. But gaps are inevitable? Gaps everywhere. Perhaps that’s part of Wilbur’s point. Title is a bit off though.marketing…
Robin Carhart-Harris
@RCarhartHarris
What are people’s views on Ken Wilber’s ideas and this book?
-
Robin Carhart-Harris
@RCarhartHarris
This is cool... “Awe-scillations”: EEG spectral and complexity representations of awe www.biorxiv.org/content/10.1101/2025.11.20.689403v1
-
Robin Carhart-Harris
@RCarhartHarris
Makes much sense to me. I’ve suspected we might be loading too much emphasis on structure.
Julie Holland, MD
@BellevueDoc
Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity
www.nature.com/articles/s41386-025-02272-3
Robin Carhart-Harris
@RCarhartHarris
Ps have a couple of relevant papers publishing on this next year. On being a rich update on the entropic brain. V promising predictive biomarker here. Validated in our species.
Robin Carhart-Harris
@RCarhartHarris
*one
-
Robin Carhart-Harris
@RCarhartHarris
What are people’s views on Ken Wilber’s ideas and this book?
-
Robin Carhart-Harris reposted
Paul Brown
@0xQuasark
𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝗷𝘂𝘀𝘁 𝗳𝗶𝗴𝘂𝗿𝗲𝗱 𝗼𝘂𝘁 𝗵𝗼𝘄 𝗗𝗠𝗧 works.
And what they found suggests your sense of self is basically a controlled hallucination your brain can just... turn off.
The world as we know it might be about to change 🧵 -
Robin Carhart-Harris
@RCarhartHarris
Many things to feel grateful for this thanksgiving but will just highlight one: @UCSF - four and a half years in and still love this institution and the fantastic city itself! ❤️ 🌁
-
Robin Carhart-Harris
@RCarhartHarris
Not that surprising a result— because the active comparator is tough competition in this design. Serial Ketamine Infusions for Depression jamanetwork.com/journals/jamapsychiatry/fullarticle/2840552
-
Robin Carhart-Harris
@RCarhartHarris
Big up Mona, Marco, Lisa, Chris and co! DMT-induced shifts in criticality correlate with self-dissolution www.jneurosci.org/content/early/2025/10/24/JNEUROSCI.0344…
-
Robin Carhart-Harris
@RCarhartHarris
“Consciousness is a miracle, truly” Michael Pollan
Robin Carhart-Harris
@RCarhartHarris
What a very special book! I’ve now finished it and will say some words about it in my forthcoming newsletter. Sign up or recommend that a friend does? carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
I’ll share some thoughts in my next newsletter. Coming v soon. Subscribe at the bottom here: www.carhartharrislab.com
Robin Carhart-Harris
@RCarhartHarris
Loving @michaelpollan ‘s forthcoming book! Giving it the works! 😊
-
Robin Carhart-Harris reposted
Julie Holland, MD
@BellevueDoc
Joseph Emerson: 'I had no idea psychedelics could have a prolonged adverse effect'
An exclusive interview with the Alaska Airlines ex-pilot whose life changed when he tried magic mushrooms two years ago
www.ecstaticintegration.org/p/joseph-emerson-i-had-no-ide… -
Robin Carhart-Harris
@RCarhartHarris
Loving @michaelpollan ‘s forthcoming book! Giving it the works! 😊
Robin Carhart-Harris
@RCarhartHarris
It’s profound and beautifully poetic. His beginners-mind type approach to topics is truly perfect for one as muddled and hard as consciousness. The first chapter on sentience is extra special.
-
Robin Carhart-Harris reposted
Andrew D. Huberman, Ph.D.
@hubermanlab
We have lost too many people around this time of year to not say it: reach out to those you haven’t heard from in a while, ask them how they are really doing, grab a coffee a walk or a hike. Chances are, someone you know is in despair. It can make a difference.
-
Robin Carhart-Harris
@RCarhartHarris
Discovering Ken Wilber: podcasts.apple.com/us/podcast/the-mindvalley-podcast/id13…
Robin Carhart-Harris
@RCarhartHarris
Seems to me “psychedelic community” and culture would do well not to get stuck in a mythic ethnocentric space, seeing those who haven’t “turned on” as “the other”.
-
Robin Carhart-Harris
@RCarhartHarris
Is there space for magic in the march to ever increasing humanism that has been happening since the renaissance?
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
And Metaphysical too? As an epistemology? No.
Robin Carhart-Harris
@RCarhartHarris
Communal too.
Robin Carhart-Harris
@RCarhartHarris
V much communal.
-
Robin Carhart-Harris
@RCarhartHarris
Ha! Nicely done 😁 I think he's on to something...
Evan McGloughlin
@evan_mcgl
“Oscillatory brain waves are creating fluctuating electric fields — that’s how the brain organizes itself.”
“Oscillations are organization. Evolution can push these waves around to create self-organization, self-control, volition.”
“Dynamic oscillatory brain firing may be the key to consciousness.”
Massively enjoyed my conversation with @MillerLabMIT. Already generate a lot of engaging chatter here on X.
Check out the full episode down below ⬇️This media couldn't be displayed. See it on the original post. -
Robin Carhart-Harris
@RCarhartHarris
Big up Patrick and Lorenzo! Read this #preprint on @researchsquare: Cross-species mapping of psychedelic gene expression reveals links to the 5HT2A receptor, cortical layers, and human accelerated regions www.researchsquare.com/article/rs-7625999/latest
-
Robin Carhart-Harris
@RCarhartHarris
Big up Naji and Jitka! pubmed.ncbi.nlm.nih.gov/41261994/
-
Robin Carhart-Harris
@RCarhartHarris
Big up Marieke and Catherine! www.nature.com/articles/s41398-025-03693-w
-
Post not available here, view on X
Robin Carhart-Harris
@RCarhartHarris
Robin Carhart-Harris
@RCarhartHarris
Mani 😢 RIP.
-
Robin Carhart-Harris
@RCarhartHarris
Meet our freaking cool study, 'Insight 2', completing in a few weeks... #ucsf carhartharrislab.com
-
Robin Carhart-Harris
@RCarhartHarris
See these trends on escalating psychedelic use.
Robin Carhart-Harris
@RCarhartHarris
Bit of a shame they lump PCP in there with psychedelics...
Robin Carhart-Harris
@RCarhartHarris
If this was escalating psychedelic-therapy, you might not consider it a problem as such but it's likely it's not that... e.g., see this...
-
Robin Carhart-Harris reposted
Ava Kwan
@avajkwan
NYT reveals a 69% increase in SSRI prescriptions among teens, with some starting as young as 11 years old. Decades after stopping, many say they’ve lost all sexual desire and passion.
No fluttery feeling of attraction when they have a crush.
No passion for the hobbies they once loved.
No excitement.
No spark or creativity.
With little evidence that SSRIs are effective, Post-SSRI Sexual Dysfunction (PSSD) can be permanent, and it’s not rare.
Why is the medical establishment allowing an entire generation to be chemically castrated and robbed of all the emotions that make us human? -
Robin Carhart-Harris
@RCarhartHarris
Enjoying this. His account from ca 25 mins is fascinating: podcasts.apple.com/us/podcast/the-michael-shermer-show/id…
Robin Carhart-Harris
@RCarhartHarris
But it’s also interesting, back in ‘21, to recall how people didn’t see the twist that US politics would deliver…
-
Robin Carhart-Harris
@RCarhartHarris
-
Robin Carhart-Harris
@RCarhartHarris
My comments in the thread might be interpreted otherwise but I admire this work. It’s so good to present surprising results and get the critical juices going… It’s how we learn…
Balázs Szigeti
@psybalazs
🚨🍄 Major new preprint alert 🍄🚨
I think these will be important results. They are not going make me popular with my #psychedelic in-group, please do not shoot the messenger!
The premise of this pre-registered meta analysis (osf.io/preprints/psyarxiv/vhs4a_v1?view_only=) is that it is biased to compare open-label trials to blind trials, it is only fair to compare open-label trials to other open-label trials. In the first case the open-label trials would gain an unfair advantage by benefitting from effects related to knowing the treatment. Therefore, we compared the efficacy of psychedelic-assisted therapy (PAT), which is open-label regardless of formal blinding to open-label traditional antidepressants (tAD; such as SSRIs/SNRIs where binded trials are very close to be truly blind) for the treatment of major depression.
We tested 3 prior hypothesis (MCID: minimum clinically important difference, which we set to be 3-points on Hamilton depression scale; differences smaller than this are clinically meaningless):
1. At the primary endpoint, the estimated mean difference between PAT and open-label tAD will exceed the MCID, favoring PAT.
2. At the primary endpoint, the estimated mean difference between blinded and open-label tAD trials will exceed the MCID, favoring open-label administration.
3. At the primary endpoint, the estimated mean difference between blinded and open-label PAT trials will not exceed the MCID.
In contrast with our prior hypothesis, we did not find PAT to be more effective than open-label tADs (H1). Not only was the difference not clinically meaningful, but practically there was no difference at all (~0.3 HAMD units). This finding means that tAD administered knowingly to patients, which is the case in real-life medical practice, is as effective as PAT. This result was robust across variations in study selection, including when we removed PAT trials on treatment-resistant depression. The improvement from baseline to endpoint was ~12 HAMD points for both treatments.
We also assessed the impact of blinding in both PAT and tAD trials. We found that for tAD (H2), but not for PAT (H3), open label is associated with better outcomes than blinded treatment. However, even in the case of tAD, the difference was much lower than the MCID.
How come hypothesis 1 failed, i.e. that PAT is no ore effective than open-label tADs, given that tAD trials are famous for small drug-placebo difference (~2.4 HAMD units), while PAT trials reported large effects (~7.3 large effects)? Well, there are two major factors:
1. As we show, open-label tAD is approximately ~1.2 HAMD units more effective than blinded treatment (H2). This effect can be interpreted as the influence of knowing one’s treatment assignment, such as positive expectancy.
2. A recent meta-analysis of depression trials found that relative to tAD trials, the placebo response is 4.0 HAMD points lower in psychedelic trials (Hsu et al., 2024). This suppressed placebo response leads to an inflated between-arm difference, as the treatment arm is measured against a lower floor.
The sum of these two effects is 1.2 + 4.0 = 5.2 HAMD units which equals the difference of the reported between-arm effects (7.3 - 2.4 ~ 5), explaining why hypothesis 1 failed.
The suppressed placebo response in PAT trials is likely attributable to the ‘know-cebo’ effect, i.e. the disappointment when patients realize they are in the control group. In PAT trials, this placebo suppression accounts for 4.0 / 7.3 ~ 55% of the total between-arm effect. In other words, ~55% of PAT’s between-arm effect is not explained by improvement in the treatment arm, but rather by the lack of improvement in the placebo arm.
In summary, we found that for the treatment of depression, PAT is no more effective than open-label SSRIs/SNRIs. Our results for psychedelics are twofold: PAT demonstrated a robust and large therapeutic effects (~12 HAMD units), which justifies optimism. On the other hand, PAT’s lack of superiority compared to SSRIs/SNRIs under equal-unblinding conditions highlights the influence of blinding integrity and presents a sobering reality check for psychedelic medicine.
In collaboration with @QuantPsychiatry and Hannah Barnett 🙏🫂
👆should be of interest to @MattBurkeMD @igoreckert @bita137 @Brainclinics @bruce_lambert @thelablab @IoanaA_Cristea @GregFonzo @MFPL6 @fredemag @n_sepeda @chchatham @LGHemkens @HolBjo @NaudetFlorian @NathanHuneke @RecoveryDoctor @iainjordan @GlynLewis9 @HengartnerMP @shayla__love @f_hieronymus @And_Cipriani @FlamelingJop @JD_Rosenblat @RickZeifman @AVoineskos @LukeJelen @TehseenNoorani @a_lisinski @PloederlM @ElliotMarseille @KingFranklinIV @JulesEvans11 @EikoFried @ExistWell @singletonion @_fernando_rosas @vincepsy @hartogsohn @MichielElk @JacobSAday @BWe1ss @sdpnayak @Colloca_Luana @JeremyHowick @mattbagg @TheBorisLab @BenColagiuri -
Robin Carhart-Harris
@RCarhartHarris
This is a big one. Classic work by @m_wall and co! Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression pubmed.ncbi.nlm.nih.gov/40329640/
-
Robin Carhart-Harris
@RCarhartHarris
Please share in your networks, especially if they focus on the Bay Area…
Robin Carhart-Harris
@RCarhartHarris
New @UCSF set&setting study is recruiting! Details here: www.carhartharrislab.com/studies-1 Or : clinicaltrials.gov/study/NCT06626139, Or go straight to this pre-screener: tiny.ucsf.edu/setsettingscreener
-
Robin Carhart-Harris
@RCarhartHarris
1/2 A classic playlist compiled by @MendelKaelen for the first @Imperial_PRG soirée into psilocybin for depression research ca. 2014-16. Special time, special music, special trial. open.spotify.com/playlist/0SHTv08aKLUHBXlC8nJ7H5
-
Robin Carhart-Harris
@RCarhartHarris
New @UCSF set&setting study is recruiting! Details here: www.carhartharrislab.com/studies-1 Or : clinicaltrials.gov/study/NCT06626139, Or go straight to this pre-screener: tiny.ucsf.edu/setsettingscreener
-
Robin Carhart-Harris
@RCarhartHarris
Please follow this link www.carhartharrislab.com/studies-1 Or this: clinicaltrials.gov/study/NCT06626139, Or QR scan this... Or, go straight to this pre-screener: tiny.ucsf.edu/setsettingscreener
Robin Carhart-Harris
@RCarhartHarris
So excited to launching the @UCSF set and setting study tomorrow. This will a seminal study for the field.
-
Robin Carhart-Harris
@RCarhartHarris
So excited to launching the @UCSF set and setting study tomorrow. This will a seminal study for the field.
-
Robin Carhart-Harris
@RCarhartHarris
Calling healthy San Francisco residents, interested in volunteering for a new psilocybin vs placebo study. Watch this space. Formal recruitment link coming soon.
-
Robin Carhart-Harris
@RCarhartHarris
I’m becoming increasing concerned about a journalistic pendulum swing wrt the topic of psychedelic science and medicine. Much does not feel constructive, well intentioned, nor well anchored to science. Perhaps because of the journalistic code to exaggerate & sensationalise.
-
Robin Carhart-Harris
@RCarhartHarris
Very excited about this. Please check and share. @eastforestmusic youtu.be/8zC-FwDBdBQ
-
Robin Carhart-Harris
@RCarhartHarris
Reading this offers a powerful endorsement for the now approved and primed 2x2 "set and setting" study @UCSF. Please get in touch if you'd like to support. www.theatlantic.com/health/archive/2024/08/mdma-fda-rejec…
-
Robin Carhart-Harris
@RCarhartHarris
Just so I can pin this for a while. @KettnerHannes - doing characteristically stellar work here.
Hannes Kettner
@KettnerHannes
/1
Ever wondered how #psychedelic effects change across the human lifespan? We explored this question in two observational studies published last month in @AmJGeriPsych & @FrontiersIn:
N=106 Older adults ≥60y www.sciencedirect.com/science/article/pii/S1064748124003361
N=435 Adolescents <25y www.frontiersin.org/articles/10.3389/frcha.2024.1364617/full -
Robin Carhart-Harris
@RCarhartHarris
Most of the world’s lifetime mental illness begins in adolescence.
Robin Carhart-Harris
@RCarhartHarris
Psychological effects of psychedelics in adolescents www.frontiersin.org/articles/10.3389/frcha.2024.1364617 Big up Nadhrah! Big up Hannes!
-
Robin Carhart-Harris
@RCarhartHarris
Psychological effects of psychedelics in adolescents www.frontiersin.org/articles/10.3389/frcha.2024.1364617 Big up Nadhrah! Big up Hannes!
-
Robin Carhart-Harris
@RCarhartHarris
Mainstream psychiatry woke up to the potential medical value of psychedelic research ca. 2016. I suspect 2024 might be the year that mainstream cognitive neuroscience finally wakes up to their scientific value.
-
Robin Carhart-Harris
@RCarhartHarris
🚨New paper!🚨 I'm delighted to share this important paper. Done with dear colleagues @PedroMediano @_fernando_rosas and co. The main result is that the entropic brain effect - so robust & reliable in resting EEG/MEG data - is greater when external sensory complexity is minimal🧵
-
Robin Carhart-Harris
@RCarhartHarris
What is the objective function for the future of psychedelic medicine?
-
Robin Carhart-Harris
@RCarhartHarris
Calling basic neuroscientists with access to EEG, ECoG or LFP recordings of spontaneous brain activity under a stimulant drug. Please DM me if you have such data and wish to collaborate. Please share.
-
Robin Carhart-Harris
@RCarhartHarris
Citizen scientists show placebo effect may explain benefits of microdosing www.imperial.ac.uk/news/216134/citizen-scientists-show-pl…
-
Robin Carhart-Harris
@RCarhartHarris
I'm pleased to share my first ever personally written piece for a newspaper: www.theguardian.com/commentisfree/2020/jun/08/psychedelic… @guardian #mentalhealth #psychedelics @Imperial_PRG
-
Robin Carhart-Harris
@RCarhartHarris
Imperial launches world’s first Centre for Psychedelics Research www.imperial.ac.uk/news/190994/imperial-launches-worlds-f…
-
Robin Carhart-Harris
@RCarhartHarris
Psychedelics on the lawn at the #idlerfestival
-
Robin Carhart-Harris
@RCarhartHarris
The Imperial Psychedelic Research Group: www.imperial.ac.uk/department-of-medicine/research/brain-…


















































































































































































































































































































































































